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1. INTRODUCTION 
 
 Siddha medicine, traditional system of healing that originated in South India 
and is considered to be one of India’s oldest systems of medicine. The Siddha system 
is based on a combination of ancient medicinal practices and spiritual disciplines as 
well as alchemy and mysticism. It is thought to have developed during the Indus 
civilization, which flourished between 2500 and 1700 BCE. According to this theory, 
it came to South India when the Dravidian people (speakers of Dravidian languages), 
who may have been the original inhabitants of the Indus valley, migrated southward. 
  Siddha medicine appears as part of Tamil culture in the earliest Tamil writings 
(Tamil is one of the principal Dravidian languages). For example, there are references 
to it in Tamil shangam literature (1st–4th century CE), including mention in the 
Tolkappiyam (“Ancient Literature”), a treatise on grammar and poetics, and in 
Tirukkural (“Sacred Couplets”), a work attributed to the Tamil poet-saint 
Tiruvalluvar. 
  According to Tamil tradition, there initially were 18 siddhars (the person who 
has achieved some extra-ordinary powers): Nandi, Agasthiyar, Thirumular, 
Punnakkeesar, Pulasthiyar, Poonaikannar, Idaikkadar, Bogar, Pulikai isar, Karuvurar, 
Konkanavar, Kalangi, Sattainathar, Azhuganni, Agappai, Pumbatti, Theraiyar and 
Kudhambai, but the Agasthiyar (Agastya) was the topmost. He is regarded as the 
originator of the Siddha medicine and also of the Tamil language. He occupies the 
same position as Hippocrates in modern western medicine. In the period of Ramayana 
he seems to have settled in the South. Thus origin of every tradition in the South, 
including language and culture, is traced back to Agastya. these individuals often are 
portrayed as having received their knowledge of the Siddha system indirectly from the 
deity Shiva. Siddhars held that the object of their study was to preserve and prolong 
life. To do so, they believed, required humans to live according to the laws of nature. 
They led simple lives themselves and were unconcerned with caste, creed, colour, or 
nationality. They contributed not only to a system of medicine but also to the 
knowledge of eternity, alchemy, and Yogic living. Some believe that the siddhars 
travelled widely to other countries to propagate their system of medicine and enrich 
the sciences. 
  Siddhars possessed ashtama siddhi, the eight great supernatural powers. These 
powers may have been attained at birth (because of one’s previous karma), by 
2 
 
chemical means, by the power of words, or through concentration. Meditation on the 
elements, beginning with the “gross” and ending with the “subtle,” enabled the 
siddhars to gain mastery over the elements. Many of the ancient philosophical tenets 
of the Siddha system continue to be relevant to modern practitioners. 
  According to the Siddha system, there are five elements that exist in nature: 
earth, water, fire, air, and ether, all of which form the original basis of all corporeal 
things. It is believed that there is an intimate connection between the macrocosm of 
the external world and the microcosm of the corporeal being. In the human body the 
element of earth is present in the bone, flesh, nerves, skin, and hair; the element of 
water is present in bile, blood, semen, glandular secretions, and sweat; the element of 
fire is present in hunger, thirst, sleep, beauty, and indolence; the element of air is 
present in contraction, expansion, and motion; and the element of ether is present in 
the interstices of the stomach, heart, neck, and head. 
  Three of the elements—air, fire, and water—are emphasized in Siddha 
medicine because they are believed to form the three fundamental components that 
make up the human constitution. These three components—vata, pitta, and kapha 
(representing air, fire, and water, respectively)—are known as humours, and their 
inharmonious interaction produces various pathological states. 
  According to the theories of humoral pathology, all diseases are caused by the 
discordant mixture of vata, pitta, and kapha. Their proportions in the body govern a 
person’s physical and mental disposition. The elements form the connecting link 
between the microcosm (the human) and the macrocosm (the world). Thus, the 
external air corresponds to the internal vata, the external heat corresponds to the 
internal pitta, and the external water corresponds to the internal kapha. Under normal 
circumstances, according to Siddha theory, vata occupies regions related to the pelvis 
and the rectum, pitta occupies regions related to the stomach and the viscera, and 
kapha occupies regions related to breath, the throat, and the head. 
  Siddhars believed vata to be self-originated and identical to divine energy. 
Imbalance of vata could be the root cause of all disease. Pitta was believed to 
represent all the characteristics of fire, such as burning, boiling, heating, and similar 
sensations. It was the name given to the heat contained in the liquid bile, which causes 
the expulsion of waste matter in the form of urine and feces, and it was believed to 
give sight to the eyes, beauty to the skin, and cheerfulness to the mind. Kapha was 
believed to supply moisture to the body and to give stability, adding to the strength of 
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the body by increasing the firmness of the limbs and thereby keeping them in 
harmony with one another. It was also thought to aid in digestion and sensation, such 
as by imparting taste to the tongue. 
  The presence and proportion of these humours within the system is indicated 
by the pulse, which is vital to correct diagnosis. 
  According to the Siddha medicine various psychological and physiological 
functions of the body are attributed to the combination of seven elements: first is 
saram (plasma) responsible for growth, development and nourishment; second is 
cheneer (blood) responsible for nourishing muscles, imparting colour and improving 
intellect; the third is ooun (muscle) responsible for shape of the body; fourth is 
kollzuppu (fatty tissue) responsible for oil balance and lubricating joints; fifth is enbu 
(bone) responsible for body structure and posture and movement; sixth is moolai 
(nerve) responsible for strength; and the last is sukila (semen) responsible for 
reproduction. Like in Ayurveda, in Siddha medicine also the physiological 
components of the human beings are classified as Vatha (air), Pitha (fire) and Kapha 
(earth and water) 
When the normal equilibrium of three humors (vatha, pitha and kapha) is disturbed, 
disease is caused. The factors, which affect this equilibrium are environment, climatic 
conditions, diet, physical activities, and stress. Under normal conditions, the ratio 
between these three humors (vatha, pitha and kapha) is 4:2:1 respectively.  
  According to the Siddha medicine system diet and life style play a major role 
not only in health but also in curing diseases. This concept of the Siddha medicine is 
termed as pathya and apathya, which is essentially a list of do's and dont's.  
  The treatment in Siddha medicine is aimed at keeping the three humors in 
equilibrium and maintenance of seven elements. So proper diet, medicine and a 
disciplined regimen of life are advised for a healthy living and to restore equilibrium 
of humors in diseased condition. Saint Thiruvalluvar explains four requisites of 
successful treatment. These are the patient, the attendant, physician and medicine. 
When the physician is well qualified and the other agents possess the necessary 
qualities, even severe diseases can be cured easily. The treatment should be 
commenced as early as possible after assessing the course and cause of the disease. 
Treatment is classified into three categories: devamaruthuvum (Divine method); 
manuda maruthuvum (rational method); and asura maruthuvum (surgical method). In 
Divine method medicines like parpam, chendooram, guru, kuligai made of mercury, 
4 
 
sulphur and pashanams are used. In the rational method, medicines made of herbs like 
churanam, kudineer, vadagam are used. In surgical method, incision, excision, heat 
application, blood letting, leech application are used. 
  According to therapies the treatments of Siddha medicines could be further 
categorized into following categories such as Purgative therapy, Emetic therapy, 
Fasting therapy, Steam therapy, Oleation therapy, Physical therapy, Solar therapy and 
Blood letting therapy, Yoga therapy, etc. 
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2. AIM AND OBJECTIVE 
 
AIM 
 The aim of this study is to evaluate the toxicity study on “PAVALA 
PARPAM” 
 
Objective 
 To collect and purify the raw materials  based on literature evidence. 
 To perform compound analysis for the purified raw drug samples. 
 To prepare the medicine based on siddha literature evidence. 
 To estimate the presence of chemical constituents by performing elemental 
analysis.  
To analyse its safety, the medicine is subjected for acute oral toxicity 
evaluation on rodents when the drug is given in single dose through oral 
administration at various dose levels. 
 To analyse its safety, the medicine is subjected for repeated oral dose 
(subacute) toxicity study evaluation on rodents when the drug is given for 28 days.
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Emetic 
 Antacid 
 Anti phlegmonous 
 Anti bilious 
   -  India materia medica  - Pg. 157 
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-Vg<g!ou{<Mole?!!
! “gVh<hk<!KjtbUr<!gz<zqjm!Lmr<gZf<!
! kqVg<G!fQr<gqb!osr<ogic!uz<zqBl<!
! we<x!sqzh<hkqgiv!ncgt<!d{i<k<KgqxK/!
hutk<kqe<!ohiKg<G{r<gt<< < < < << < < < << < < < <!
! Pavalam is chiefly used in cough, pthisis, asthma, fever, urinary disease, etc. 
Dose is 3-12 grains, Thrice a day after meals.  It was administered to cases of chronic 
bronchitis and Pulmonary Tuberculosis and found useful in both classes of disease’. 
- Indian Materia Medica – Page 157 
“Hjvbqzih<!hutk<ke<jl!HgZOue<!GeqK{<hi<!
! SvoliM!uxm<sq!&s<Sk<okib<uVf<!kigl<!Osmz<!
-VlOz!uikhqk<k!lqjehbju!fQg<Gole<X!
! uvlzqLequi<!sqk<ki<uGk<k!uigmr<gt<!osiz<Zl<” 
- hkiIk<k!$mil{q!hg<gl<!211!
kqxlie!LVg<gl<H,!-kp<OhiZf<kie<!
! ! kqsi$ve<!sjkbqz<!dx<hk<kqbie!
! Gvlie!hupfqxl<!geLliGl<!
! ! GVkqbi!ljzs<sqxgqz<!dx<hk<kqbie!
! kqxjlbie!hupk<kqe<!G{k<jkg<OgT!
! ! squf<KOl!kie<!gmzqec!ke<eqz<kiEl<!
hqxlie!huplie!ogicOb!Ohie<X!
! ! ohVl<fk<jkh<!hqvjhBlib<!-Vg<Gf<kiOe!
- Ohigi<!8111!hg<gl<!278!
  T.V.sil<hsqul<hqt<jt! ngvikqbqz<! Vol-V hg<gl<! 4334! z<! hutk<kqe<!
Okix<xl<!hx<xq!Gxqh<hqmh<hm<Mt<tkiuK!
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  It is hard calcareous substances found in the ocean, secreted by marine polyps 
for their common support and habitation.  The stony .... secreted by them continuously 
grow like plants which are called “Coral reefs” 
hutk<kqe<!h{<Hgt<< < < << < < << < < <!
! hutk<kqx<G! G{r<gt<?! Gx<xr<gt<! we! -V! h{<Hgt<! G{himl<! kiK!
sQul<!hg<gl<!457z<!%xh<hm<Mt<tK/!
G{r<gt<!7< << << < !
! sqf<K~vl<?! osl<l{q?! osr<gib<?! LSLSg<jg! geq?! uQjvg<geq!
liKjtg<geq/!
hutk<kqe<!Sk<kqLjx< < << < << < < !
! hutk<jk! yV! fit<! LPuKl<! hps<six<xqz<! Dxjuk<K! lXfit<!
ouf<fQiqz<!gPuq!dzi<k<kq!wMk<Kg<!ogit<t!Sk<kqbiGl</!
- G{himl<!kiKsQul<!hg<gl<!459!
- sqgqs<sivk<ekQhl<!hg<gl<!52!
hutk<kqe<<< << <<!OuX!Sk<kq!Ljxgt<< << << <!
! ogichutk<jk! yV! K{qbqz<! Lcf<K! hSuqe<! Oliiqz<! Ohim<M!
&e<Xfipqjg!Dxqehqe<!wMk<Kg<!gPuq!dzi<k<kq!juk<Kg<!ogit<tUl<!
- uQvliLequi<! fsgi{<mou{<hi!
hg<gl<!92!
!
hutk<jk! wZlqs<js! six<xqz<! 2! sill<! gizl<! hiuje! osb<K! hqxG!
ouf<fQiqz<!nzl<hq!wMg<g!Sk<kqbiGl</!
- vsvk<e! sLs<sbl<! wEl<! sqk<k!
vsibe!F~z<!hg<gl<57!
!! hutk<jk!4!fit<!sl<hQvs<six<xqz<!Dxh<Ohim<M!wMg<gUl<!
- 29!sqk<ki<gt<!vi\juk<kqb!Ohikqeq!
hg<gl<!214!
“KgqjvOb!nPg<ogipqf<K!KuqkLl<!h{<{ilz<!
! ugqi<uVuje!bue<g{<!ueqjkOb!-eqKOg{<li!
dgqi<Leq!-vk<kgisl<!dh<hsl<uz<jz!Osijh!
! fuqi<uki!osb<fQI!hqe<ei<fuqz<oue!oue<XLe<Oe”!
- ngk<kqbi<!hqe<!91.hg<gl<!38/!
!! hutlieK! –! sbOvigl<?! gisl<?! vk<khqk<kl<?! Ofk<kqv! Ovigr<gt<!
-jugjtk<!kQIg<guz<zK/!
.vsvk<e!sLs<sbl<!hg<gl<!57!
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!! hutk<kqeiz<! nkqkigl<?! nVsq?! Jbl<?! gisl<?! sbOvigl<?! gilijz?!
SvOki]l<?!kqiqOki]l<?!fiuxm<sq?!hqk<k!hi{<M?!HPuq]l<?!uqf<Kfm<ml<!OhiGl</!
- G{himl<!jgObM!hg<gl<!87!
!! hutk<kqeiz<! SvOki]l<! =jt?! gisl<?! szg<gm<M?! kigl<?! npjz?!
fQIs<SVg<G?!Ohkq?!uqf<K!fm<ml<!Lkzqbe!G{liGl</!
- nEhu! juk<kqb! Okuvgsqbl<!
higl<!2!hg<gl<!:6!
huthx<hk<kqe<!ohiKg<G{l<< < < < << < < < << < < < <!
! “fx<hut!fQx<jx!fbf<OkBm<!ogi{<OmiIg<G!
! ! osix<hSv!lQjt!SgliGl<!.!gx<hvOs!
! kigLme<!npjzk<km<M!fQIg<!gm<omiqs<sz<!
! ! OugLm!OeiMl<!uqjvf<K”!
- hkiIk<k! G{uqtg<gl<! .! kiKsQul<!
hg<gl<!368!
-jth<H!Ofib<g<G!kvh<hMl<!hupl<< < < < < << < < < < << < < < < <!ogi{<M!osb<bh<hMl<!lVf<Kgt<< < < < < << < < < < << < < < < <!
hut!hx<hl<< << << <!
! ntU!! .! h{wjm!)599!lqgq*!
! nEhiel<! .! ou{<o{b<!
- ngk<kqbi<! juk<kqb! vk<kqe!
SVg<gl<!hg<gl<.269!
hut!hx<hl<< << << <!
! ntU!! .! 2.4!Ge<xq!)241.4:1!lq/gq*!
nEhiel<! .! Oke<?!ofb<?!ou{<o{b<!
Nkivl<! .! Okjvbi<!gih<hqbl<?!hg<gl<!41!
hut!hx<hl<< << << <!
! ntU!! .! 2!Ge<xq!)241!lqgq*!
! nEhiel<! .! hiz<?!ofb<?!Oke<!
- biOgiH! juk<kqb! sqf<kil{q! 811!
hg<gl<!4:7!
hut!hx<hl<< << << <!
! ntU!! .! 2!Ge<xq!)241!lqgq*!
! nEhiel<! .! hiz<?!ofb<?!Oke<!
Nkivl<! .! biOgiH!uik!$k<kqvl<!hg<gl</38!
! !
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hut!hx<hl<< << << <!
! ntU!! .! 2!Ge<xq!)241!lqgq*!
! nEhiel<! .! hiz<?!ofb<?!Oke<!
- DIusq!vsuik!sqm<gi!
)hR<svk<kqel<*!hg<gl</327!
hut!hx<hl<< << << <!
! ntU!! .! ½!!Ge<xq!)76!lqgq*!
! nEhiel<! .! ofb<!
- hkiIk<k!G{!uqtg<gl<!
kiKsQuuGh<H!hg<gl</369!
hut!hx<hl<< << << <!
! ntU!! .! ¼ !!Ge<xq!)44!lqgq*!
! nEhiel<! .! hiz<?!ofb<?!Oke<!
! ! ! ! ! ! .g{<[silqbl<!we<El<!!
juk<kqb!Osgvl<!hg<gl</26!
hut!hx<hl<< << << <!
! ntU!! .! ½ -1!!Ge<xq!)76.241!lqgq*!
! nEhiel<! .! ofb<?!Oke<!
! ! ! ! ! ! .g{<[silq!hvl<hjv!juk<kqbl<!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!hg<gl</496!
hut!hx<hl<< << << <!
! ntU!! .! ½!!!Ge<xq!)76!lqgq*!
! nEhiel<! .! ofb<?!ou{<o{b<!
- sqgqs<sivk<kqe!kQhl<!hg<gl</!335!
ogic!hut!hx<hl<< << << <!
! ntU!! .! 76.311!lq/gq!
! nEhiel<! .! ofb<?!ou{<o{b<!
- hivk! lVf<K! osb<Ljxgt<!
hg<gl</62!
hut!hx<hl<< << << <!
! ntU!! .! ½!!!Ge<xq!)76!lqgq*!
! nEhiel<! .! Oke<!
- sqk<k!juk<kqb!kqvm<M!hg<gl</261!
! !
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hut!hx<hl<< << << <!
! ntU!! .! 4.6!Ge<xq!)4:1.761!lqgq*!
! nEhiel<! .! hiz<?!ou{<o{b<?!k{<{QI!
- svOhf<kqvi<!sbl<!dtlif<jk!Ovig!
sqgqs<js!hg<gl</73!
hut!hx<hl<< << << <!
! ntU!! .! 71!lq/gq/!
! nEhiel<! .! hef<okir<gqfQI!+ Oke<!
- nEOhig!juk<kqb!fufQkl<!higl<!
.4!hg<gl</238!
ogichut!S{<{l<< << << <!
! ntU!! .! 3.4!Ge<xq!)371.4:1!lqgq*!
! nEhiel<! .! ou{<o{b<?!ofb<?!Oke<!
- nEOhig!juk<kqb!fufQkl<!higl<!
.4!hg<gl</24:!
hut!sqx<hq!hx<hl<< < << < << < <!
! ntU!! .! 4.6!Grain 
! nEhiel<! .! ou{<o{b<?!ofb<?!Oke<!
- The pharmacopoeia of Siddha 
Research of Medicine Pg.No.29!
hut!sqVr<gq!hx<hl<< < << < << < <!
ntU!! .! 3.5!Grain 
! nEhiel<! .! ou{<o{b<?!ofb<?!Oke<!
- The pharmacopoeia of Siddha 
Research of Medicine Pg.No.31!
hut!hx<hl<< << << <!
! ntU!! .! 3.4!niqsq!wjm!)241.2:6!lqgq*!
! nEhiel<! .! ou{<o{b<?!ofb<!
- fl<fim<M!juk<kqbl<!hg<gl<!/372!
hut!osf<K~vl<< << << <!
ntU!! .! ½ -1!!Ge<xq!)76.241!lqgq*!
! nEhiel<! .! ofb<?!Oke<!
! ! ! ! ! .g{<[silq!hvl<hjv!juk<kqbl<!hg<gl</232!
! !
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nEhiel<<<<! ! ! ! kQVl<Ofib<gt<Q < < <Q < < <Q < < <!
ouf<fQI! ! ! ! -vk<k!&zg<%X!
si<g<gjv! ! ! ! hUk<kqvl<!
our<gib!siX! ! ! sk<kq!Ge<ll<!
nkqlKvl<! ! ! ! $kgse<eq!
liuqzr<gh<hm<jm!siX! ! gqvi{q!
!
hups<S{<{l<< < << < << < <!
! Sk<kq! osb<k! hupk<jk! yV! sm<cbqz<! Ohim<M! wZlqs<sl<! hps<six<jxBl<!
Htqk<k!OlijvBl<!sllig!gzf<K!nkqz<!uqmOu{<Ml</!!huplieK!5!nr<Gzl<!
Np<f<kqVg<gOu{<Ml</! ! -kje! nMh<Ohx<xq! sqXkQbig! wiqk<K! fQI! S{<ce! hqe<H!
yV!fit<!oubqzqz<!juk<K!Lbz<!-vk<kk<jk!uqm<M!hqsxq!oub<bqzqz<!juk<K!
lXfit<! Ym<czqm<M! OlOziM! &c! sqjzl{<! osb<bilz<! 411! hzl<! uxm<cbqz<!
Hmlqm<M!Nxqehqe<!wMg<g!gMr<givs<!S{<{lib<!-Vg<Gl</!
! ntU!! ! ;!  3.4!Ge<xqobjm!)371.5:1!lqgq*!
! Kj{lVf<K! : ou{<o{b<?!hSuqe<!ofb<?!Oke<!
! kQVl<!Ofib<gt<! ;! sbl<?!-Vlz<?!Suisgisl<!
- nEOhig!juk<kqb!fufQkl<!higl<!
4!hg</24:!
!! -h<hx<hk<kqjeg<! ogit<Tl<! gizl<?! giIk<kqjg?! liIgpq?! hr<Geq! fQr<gqb!
lx<jxb!ye<hK!likr<gTliGl</!
Wx<x!fqzl<;< << << < !!
!! lVkl<!
hx<hk<kqe<!lgqjl< < << < << < < !
! -K!uqgivk<Kme<!himg<%cb!okieqjb!fQg<gqs<!Sk<k!Svr<gjtBl<?!fjv?!
kqjv?! &h<H! sig<gimigqb! Gx<xr<gjt! fQg<gqg<! gibsqk<kqjbBl<! Okg!
ue<jljbBl<!ogiMg<Gole<hjk?!
! “sqf<K~vk<Kh<!himmjz!OsIgib!u{<jlB{<mil<!
! sqf<K~vk<Kh<!himmjz!osb<BLe<Oe”!
hk<kqbl<< << << <!
! -kje! d{<[r<gizk<Kh<! HjgbqjzjbBl<! oh{<! Ohigk<jkBl<!
kuqi<g<g! Ou{<MuOk! hk<kqbk<kqe<! -bz<H/! ! -jk?! “hqvl<gk<kqvLl<! -tl<hqcBl<!
uIs<sqkOl”!we<El<!Okve<!himziz<!nxqbzil</!
! !
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osf<K~vl<< << << <!
! yV! hzl<! hupk<jk! heR<siX?! hVk<kqs<siX?! Yiqkp<! kiljvs<siX?!
dk<kil{qs<siX?! gLgR<siX?! gml<hqe<siX! -jugt<! yu<ouie<xiZl<!
keqk<keqbig! njvk<K! Hmlqm! Ou{<Ml</! ! hx<hk<kqx<G! osie<e! uqkqLjxgjt!
-kx<G!nEsiqg<gUl</!
ntU!
! lqtgqz<!ye<X?!-v{<M?!&e<X?!fie<G?!Jf<K!%Xgtil</!!-ju!LjxOb!
dk<kll<?!lk<kqll<?!nkll<?!K{qH!neilk<kiGl</!
!
nEhiel<<<<! kQVl<!Ofib<gt<Q < < <Q < < <Q < < <!
ofb<! gbOvigk<jk!Osi<f<k!dh<H!uif<kq!
hSf<kbqi<! gMh<H!uikl<!
hSOliI! fMg<Guikl<!
hSl<hiz<! ghSvl<!
hjeFr<G! ghgisl<!
Ktsqs<siX! gz<zQvz<!uQg<gl<!
fQI! hqch<H!uikl<!
-tfQI! hqk<kgisl<!
!  !
!
! !
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!
!
!
!
!
!
Cleome gyandra 
jkOujt!
!
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jkOujt!
OuXohbi<gt<;< << << < !
!! klqp<!!! ;! nSg{<mi<?!hijzbl<!uquqkl<!
! okZr<G!! ;! Vaminta 
 ljzbitl<! ;! Karvela 
 ge<eml<! ;! Shrikala 
! Sans.  : Ajaganda 
 Hindi  : Hurhur 
!! -K!Oujtbqz<!yV!ujg/!
hbe<hMl<!dXh<H;< < << < << < < !
!! -jz?!H,?!uqjk?!Oui<!
Sju!;!
!! gii<h<H!
ke<jl!;!<<< !
!! ouh<hl<!
hqiqU;!
!! gii<h<H!
osb<jg<<< !
!! -jz!! ;! kch<H{<mig<gq!
! uqjk!! ;! HPg<ogiz<zq?!-squgx<xq?!ngm<Muib<ugx<xq?!!
uqbi<ju!ohVg<gq!
! “Oujt”! ! we<gqx! ohbiqe<gQp<! gib<Oujt?! Lm<giOujt?! fz<Oujt?!
fib<Oujt?! jkOujt! we<gqx! ohbviz<! upr<Gl<! H,{<Mgtqz<! ! &e<Xg<G<!
fie<Gg<Gl<! ohiVk<kl<! lqgU{<M/! &e<xiuke<! H,! ou{<jl?! fie<giuke<! H,!
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lR<st<! )-kx<Og! gim<Mg<gMG! we<Xl<! ohbi<*/! Jf<kiuK! sqxqK! -jzbqZl<?! H,!
fqxk<kqZl<?! dVuk<kqZl<! sqxqK! OuXhMl</! H,! ou{<jl! gzf<k! fQzfqxliBl<?!!
ohiqkigUl<! -Vg<Gl</! -ke<! s&zs<! six<Xme<! hSuqe<! hiZl<! si<g<gjvBl<!
gzf<K!dm<ogi{<Muv!-vk<k!hQfsl<!fQr<Gl</!
- G{himl<!&zqjg!uGh<H!
!
! !
!
!
!
!
  
 !
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Ghee 
ofb<<<<!
!
!
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ofb<<<<!
ofb<<<<!ohiKg<G{l<< << << <!
! “ofb<B{!U{<mju!Ofi<Uxs<!osb<KOle<!
! olb<jbBf<!kq{<{qb!OlVoues<!osb<Bl</”!
!! ofb<jb! Ou{<cb! ntuib<! d{Ugtqx<! Osi<k<K! dm<ogit<tqe<?! n0K!
d{<m! d{jus<! siqh<hMk<kqs<! siQvk<kqx<G! lqGf<k! hzk<jkBl<! H]<cjbBl<!
d{<mig<Gl</!
hSuqe<!ofb<g<G{l<< < < << < < << < < <!
! “kigLp!jzSm<gl<!uif<kq!hqk<kl<!uiBhqv!
! Olgl<!ubqx<oxiqU!uqg<gzpz<!.!ligisr<!
! Ge<ll<!uxm<sq!Gmx<Hvm<m!z^<kqSm<gR<!
! osie<&zl<!Ohig<Gfqjxk<!Kh<H”/!
! hSuqeK! ofb<bieK! kigl<?! dpjzh<hq{q?! nkqSm<gOvigl<?! uif<kq?!
hqk<kikqg<gl<?! uik! uq]l<?! uqv{h<! hqvOlgl<?! ubqx<xqoziqU?! hqk<k! uqg<gz<?!
-Vlz<?! ubqx<Xuzq?! uxm<sq?! sqjeh<H?! Gmz<oftqkz<?! n^<kq! $l<hz<?! &z!
Ovigl<!Ngqbux<jx!fQg<Gl</!
hSofb<<<<!
! -keiz<! kigl<?! dpjzh<hq{q?! nkqSm<gOvigl<?! uif<kq?! hqk<kikqg<gl<?!
uikl<?! hqvOlgl<?! ubqx<oxiqU?! hqk<k! uqg<gz<?! -Vlz<?! ubqx<Xuzq?! Gmx<Hvm<mz<?!
n^<kq?!Osil<hz<?!&zOvigl<?!uxm<sq!-ju!fQr<Gl</!
givil<hS!ofb<< << << <!
! -keiz<! Ofk<kqvk<kqx<G! ytqBl<?! siQv! H]<cBl<! ohix<sibZl<! d{<miGl</!!
g{<?!HVul<?!ofx<xq?!sqvS!-jugjth<!hx<xqb!Ofib<gt<!fQr<Gl</!
wVjl!ofb<<<<!
! -keiz<! nxqU?! npG?! g{<o{itq! -jugt<! lk<kqhlil</! ! uikhqk<k!
Oki]l<!gvh<hie<!-ju!d{<miGl</!
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out<tim<M!ofb<< < << < << < <!
! -K?!ghikqg<gk<jkBl<?!uikOgihk<jkBl<!fQg<Gl</!!siQvk<jk!
uti<h<hKle<xq?!g{<[g<G!ytqjbBl<!d{<mig<Gl</!!hk<kqbk<kqx<Gl<!dkUl</!
osl<lxqbim<M!ofb<< < << < << < <!
! -keiz<!ghOfib<!nkqgiqg<Gl</!
gzh<Hofb<<< <!
! wVjl?!out<tiM?!hS!-jugtqe<!ofb<!Osi<f<k!gzh<H!ofb<biz<?!
Sg<gqzLl<!kQheLl<!d{<miGl</!!dmz<!uZg<Gl<?!hqk<kOki]l<?!Okgg<!
ogikqh<hizigqb!hqk<k!Svl<!Ohil</!
!
!
!
!
!
!
! ! !
!! !
!
! !
!! !
!! !
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MODERN ASPECT 
RED CORAL 
Zoological aspects 
Classification: 
 Kingdom   : animals 
 Sub kingdom   : radiates 
 Infra kingdom  : coelenterate 
 Phylam   : cnidaria 
Class    : Anthozoa 
Sub- class    : Alcyonaria (octocorallia) 
Order    : Gorgonacea 
             Family    : corallidae 
            Genus   : corallium 
Species   : rubrum 
Zoological name   : Corallium rubrum (Linn. 1758) 
Synonyms             : Madrepora rubra (Linn.1758) 
                                     Isis nobilis 
                                     Gorgonia nobilis (Linn. 1758) 
- www.sn2000.taxonomy.nl/main/classified 
Vernacular Names 
  Tamil    : pavalam 
 English   : Red coral,  noble coral 
 Sanskrit   : pravalam 
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 Hindi    : parvara 
 Gujarati   : parvalc 
 Kannadam   : havala 
 Telugu   : pagadamu 
 Malayalam   : poalam 
 Germany   : koralian 
 Italy    : coralio 
 French   : corali rouge 
 Arab    : bussud 
 Persian   : marjan 
 Spanish   : coral rojo 
 Singalam   : bubalo 
- Nadkarni, Indian material medica vol 2, page 1 
Varieties of corals 
 There are varieties of corals like red corals black colrals, white coralls, blue 
corals, stony corals, horny corals, soft corals and organ pipe corals.Here the red coral  
[or] precious coral has been taken for my dissertation. 
Distribution 
 The  red coral inhabits the rocky bottoms of seas, chiefly in the western and 
eastern Mediterranean  [from Greece and Tunisia to the straits of Gibraltar including 
Corsica] , red sea, Persia and Arabian gulf, atlanic ocean. 
 It has been reported in the malasian waters, islands of japan , Sumatra and 
Maldives . red corals flourish at depths of 30-200m.  
- Wealth of Indian part 2 , page 323 
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Habitat and biology 
 A rocky bottom spiecies inhabiting depth with weak luminosity mainly 
between  20-200m depth. At their shallowed depth distribution . it is characteristic of 
the corallium rubrum faicies in the bio cenosis of semi dark caves. Coral exploitation 
is progressively restricting their occurrence at the deeper range of their bathymetric 
distribution. C.rubrum is slow growing a few centimeters per year and long living 
species . Diet based on small zooplankton organisms captured with the help of the 
polyps tentacles. 
 C. rubrum population are infested by a variety of endobiotic boring sponges. 
Size  
            Some colonies attains 20cm height. The base of the largest specimens can 
attain to 3cm of diameter. An intensive exploitation reduced, however, the maximum 
size of colonies. 
Charateristics  features 
             Rigid colonies may branch in all directions, given a bushy shapes. Calyces 
short and hemispherical are distributed on the branches. Expanded polyps in living 
colonies are white transparent and eight tentacles having fine pinnules without 
sclerties. 
  Polyps are retracted within calices once corals have been captured. Calcareous 
spicules (seleries) from the crust, radically symmetrical are warty with a short stick 
shape 
Colour 
  Often dark red, sometimes and rarely pink or even white 
                                                    -    www.fao.org/figts/servle/species 
   In smell it resembles frankincense it easily break with crackling sound. 
                                                            -Indian material medical vol.2, page 157 
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Growth of corals 
   Corals are calcareous skeletons the minute marine organism possessing a 
more or less cylindrical body, a mouth surrounded by a large number of tentacles and 
a cavity in which the food is digested. The body wall consists of an outer ectoderm, an 
endoderm and mesogloe. In the simplest form the skeleton is in the form of minute 
irregular deposits of calcium carbonate called spicules,  lodged within the mesogloea. 
 In some forms the spicules become fused together and form a continuous tube 
inside the polyp, whie in some other a hard rod like axis through the boby is formed. 
In the true (or) stony corals, the principal builders of coral reef and islands, the 
skeleton is secreted externally at the base and lower part of the body.  
 Coral reefs 
   The true or study coral is most colonial and is provided with a hard calcareous 
exoskeleton secreted by the epidermis and lying wholly outside the polyp body. The 
skeleton of the colony as a whole is termed corallium and of each polyp, corallite. As 
the colony grows, the polyps on the outer edges multiply, smothering out the lower 
ones and growing upon their skeletons, continuously with drawing calcareous 
material from the water. Under favorable conditions the growth of coral reefs is 
sufficiently rapid, requiring a reversion of navigation charts every 20 years. 
       Among the organisms playing a role in the formation of coral reefs are: 
coralline alage, fleshy alcyonaceae, millipores and sponges. Coral formation are 
inhabited by a vast number of marine creatures such as sea urchins, star fish, crabs 
and number of brightly coloured fish. 
       Reefs corals are limited in their vertical distribution. They don’t grow below 
50m and flourish best above 30m. exposure to sun, excessive turbidity of sea water 
and impact of fresh water during heavy rains are unfavourable for coral growth. Coral 
reefs are usually classified as, 
a) Fringing reefs. 
b) Barrier reefs. 
c) Atolls. 
  Corals reefs are valued as a source of lime. 
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Parts used 
   The calcareous shell or skeleton. 
  Composition of red corals 
  The pigments of red corals are unidentified organic compounds of iron. 
Calcium carbonate – 86.974% 
Magnesium carbonate – 6.804% 
Calcium sulphate  - 1.271% 
Ferrous oxide – 1.720% 
Organic matter – 1.350% 
Water – 0.550% 
Phosphoric acid (p2o5), silica etc. – 1.331%  
                                        -wealth of india part 2, page 325 
Animal (or) organic matter -8pc 
Carbonate of lime – 8.3pc 
Magnesium carbonate -3.5pc 
Oxide of iron – 4.5pc 
- Nadkarni, Indian material medica, vol 2, page 157. 
Specific gravity 
            The specific gravity of the precious corals ranges from 2.6 to 2.7 and the 
hardness 3.75. 
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CLEOME GYNANDRA  
THAIVELAI 
  Cleome gynandra is used as a medicinal plant and can be found in all over 
world .It grows as a weed in paddy fields and also in road sides and in open grass 
lands. Cleome gynandra L. commonly known as spider plant belongs to the 
Capparaceae family and subfamily Cleomoideae.Cleome is a largest  genus includes 
601 plant species. Cleome is a major group of angiosperms, comprising many species 
found in tropical and sub-tropical areas of the globe. Of more than 600 plants, 206 
(34.3%) plants are having accepted species.  
BOTANICAL DESCRIPTION: 
MORPHOLOGY: 
  It is an erect, annual herb up to 250-600 mm tall; much branched and 
sometimes becomes woody with age. Stem- The stem is sticky with glandular hairs 
and marked with longitudinal parallel lines.  Leaves-Leaves are palmately compound, 
with 3-5 leaflets. The leaf stalk is 20-50 mm long with glandular hairs. The leaflets 
radiate from the tip of the leaf stalk, are 20-100 x 8-40 mm, smooth or with glands, 
and taper toward the base; on the under surface, are smooth to   finely glandular, and 
often with scattered multi cellular hairs on the main nerves. 
INFLORESCENCE 
  The inflorescence is a terminal raceme, many-flowered, elongating in fruit; the 
bract is 3-foliolate to simple above, resembling the leaves but smaller and sessile. The 
flower stalk is 10-20 mm long with glandular hairs. Petals are white, sometimes 
fading to rose pink, 10-20 x 3-5 mm, rounded at the apex, abruptly narrowed to a 
basal claw. 
FLOWERS  
  bisexual, bracteate, white or tinged with purple  Fruits-The fruits are in 
capsule form. The capsule is linear, sub-erect to spreading, 30150 x 2.5-5 mm; the 
persistent style is 2 mm long and the valve is thin-textured, glandular with hairs. The 
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seeds are brown, circular in outline, 1.5 mm in diameter, with an obscurely netted 
surface.  
MICROSCOPIC STRUCTURE: 
  Dark brown, oily; under microscope shows a number of fragments of 
epidermis of testa consisting of thin-walled, polygonal cells; groups of cells, 
resembling like stone cells, reddish-brown with non-lignified walls; a large number of 
oval, rounded or irregularly shaped protein bodies; starch and crystals absent1 Leaf 
thickness ranges from 112-398 µm. Upper epidermis single layered, large, slightly 
deep, tubular cell contains thick lamellar cuticle. Multiseriate glandular hairs 
embedded in both surfaces, foot 2-3 celled embedded in epidermis, bi-celled stalk, 
large columnar, head is about 3-5 tiered clavate. Mesophyll consists of palisade and 
spongy parenchyma; palisade cells are adaxial hypodermal, single layered, long 
rectangular with little inter cellular spaces, chloroplast abundant: spongy parenchyma 
2-3 layered with large, intercellular spaces. Vascular bundles large, collateral and arc-
shaped in primary veins, small and round in secondary veins. Xylem towards adaxial 
side, phloem in abaxial, bundle sheath large, parenchymatous cells distinct, barrel 
shaped, bundles of tertiary veins buried between mesophyll cells. Lower epidermis 
single layered, large, thick walled; guard cells large, thick walled, vertically 
embedded to subsidiary cells thick-cuticle, lamellar, forming very minute outer ledges 
over guard cells.  
Epidermis in surface view  
  The costal epidermal cells are large axially oriented 5-10 times longer than 
broad, rectangular to rhomboidal in shape, thick walled and straight. Intercostal cells 
are large and in variously shaped, thin walled, slightly to deeply sinuous. Evidently, 
three types of glandular hairs, namely uniseriate clavate, multiseriate-spherical and 
multiseriate-clavate were found in both costal and intercostal regions. 
Vernacular names in India: 
 Sanskrit        : Pasugandhi,Ajagandha 
 Assamese     : Bhutmulla  
Bengali         : Hurhuria, Shulte  
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English         : Dog Mustard  
Gujarat         : Talvani, Dhelitalavan  
Hindi            : Hulhul, Hurhur, Kavalia  
Kannada       : Naram bele Soppu, Nayeetulasi  
Kashmiri      : Gandi Buti  
Malayalam   : Atunari vela  
Marathi        : Tilvan, Bhatvan, Mabli, Tilavana, Tilvant  
Oriya            : Anasorisia, anasorisa,Hulhulia  
Punjabi        : Bugra  
Tamil           : Thai valai, Thal velai . 
Telugu         : Vaminta, Vayinta  
Taxonomic position of Cleome gynandra L : 
 Kingdom: Plantae  
 Division: Angiosperms 
Class:             Dicotyledones   
Order:             Capparidales (Capparales)  
Family: Cleomaceae   
Genus:             Cleome   
Species: Gynandra. 
Phytochemical importance of C. gynandra:  
  Qualitative phytochemical screening of the powdered leaf revealed the 
presence of following class of compounds. A good number of phytochemicals have 
been isolated from different parts of white mutant C. gynandra which confirms its 
current understanding of nutritional claims and pharmacological evidence, whereas a 
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few compounds, namely, clenbuterol, stearin compound, bicyclohexyl derivatives, and
 (5Z,8Z)-3-hydroxypropyl dodeca-5,8-dienoate only been isolated from 
the pink mutant variety, only available in N.E states. Further summarizes the isolated 
phytochemicals from both the mutant varieties of C. gynandra with respective 
citations.  
Pharmacological importance of C. gynandra: 
   The pharmacological importance of C. gynandra is referred in Ayurveda;
 Gulma (tumor, irregularity, or diverticulosis), Krmiroga (worm infection), 
Asthila (Prostate enlargement), Kandu (pruritus), and Karnaroga (ear infections). 
The indigenous information s traditional medicine has been figured, reported, and 
eventually wind up noticeably with composed frameworks of the drug. 
  The following are some therapeutic investigation reported by various 
researchers from India and from other nations as well:  
 Sap from leaves utilized as pain relieving agent, especially in cerebral 
pain. 
 Sap from pounded leaves is pressed  into ears, nostrils, and eyes to treat 
epileptic fits and ear infection. 
 A decoction or mixture of bubbled leaves and/or roots is regulatedto: 
 Encourage labor pain in pregnant ladies. 
 Treat stomach-throb and constipation. 
 Treat conjunctivitis. 
 Treat serious thread worm disease.  
 Relieve burning chest pains. 
 The leaves have anti-inflamatory activities and are utilized  to treat joint 
inflammation. 
 Leaves are rubefacient and vesicant and used to treat neuralgia, otalgia, 
rheumatism, and stiffness. The leaves are rubbed on the affected parts. 
 In Taiwan, it is utilized  to treat looseness of the bowels, gonorrhea, fever, 
and rheumatoid arthritis. 
   In India, the plant has been usually utilized as a rubefacient and anthelmintic 
agents. Leaves are applied directly over the injuries to prevent sepsis. The plant also 
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used to treat piles, different stomach aches and in tumor. The juice of the root is 
utilized to treat fevers. 
 Bruised leaves are applied to boils  to stop pus discharge.  
 Infusion from leaves is utilized to treat iron  deficiency. 
 Sap from the leaves used to cure intermittent intestinal sickness. 
 Leaves are rubbed onto the skin to relieve pneumonia. 
 An infusion of the leaves utilized as an eyewash.  
 Seeds are anthelmintic and rubefacient and are consumed for the removal of 
roundworms, or a mixture is applied externally on the stomach as a painkiller. 
 Seeds are blended with oil and applied to the scalp to treat headache. 
 Mixture of seed controls coughing. 
 Seeds are also utilized for veterinarians to treat stomach pains.  
 Leaves and the plant have anti-ticks and fleas preventive properties.  
 A decoctionof roots is accounted for to have gentle febrifugal properties 
High in vitamins and micronutrients: 
   Spider plant is nutritious. It is known to contain high levels of beta-carotene, 
vitamin C, and moderate levels of calcium, magnesium, and iron. Regarding vitamin 
A content, an analysis carried out in Tanzania showed that the in vitro accessibility of 
all-trans-β-carotene in spider plant was the highest (26%) compared with cowpea, 
amaranth, sweet potato leaves, pumpkin, or combinations of these vegetables. The 
study also showed that when spider plant leaves were cooked with oil, in vitro 
accessibility increased to 53%. However, the total amount of all 9cis β-carotene did 
not significantly increase with the addition of oil. The analysis showed that spider 
plant could contribute 72% (without addition of cooking oil) to 477% (with addition 
of cooking oil) of the daily vitamin A requirement. The daily requirement for children 
is set at 400 µg RE with an assumption that 50% of all accessible β-carotene will be 
converted to retinol in mucosa.  The weight of a vegetable portion consumed varied 
from 52 to 157 g, with a median weight of 84 g used as the basis for calculations.  
  The plant contains high crude protein, lipids, and phenolic compounds. The 
amino acid profile in spider plant is better than groundnut, as all amino acid contents 
are higher.  
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  Protein consumption can be compromised by consuming food containing 
elevated levels of trypsin, which inhibits proteases activities. A study showed that 
trypsin inhibitor activity in spider plant was low (0.45 and 0.32 µg/mg dry weight of 
plant respectively before and after boiling for 5 min) compared with the soybean 
reference (1.32 and 1.03 µg/mg dry weight of plant respectively before and after 
boiling for 5 min).  
  Vegetables can lose their vitamin C content after cooking, but showed that 
spider plant best retains vitamin C compared with other vegetables. In fact, when 20 g 
of spider plant are cooked in 100 mL (very little) or 400 mL (excess) water, the losses 
were 5.3% and 18.3% respectively. By comparison, losses for amaranths A. 
graecizans were 86.2% and 46.4%, and A. spinosus  96.5% and 67.0%; for Ethiopian 
mustard (Brassica juncea), 51.4% and 86.1%; Moringa (Moringa oleifera) 85.4% and 
98.5%; and bitter lettuce (Launaea cornuta) 93.5% and 94.5%. Understanding why 
spider plant retains most of its vitamin C after cooking would help indigenous 
vegetable breeders improve the nutritive value of this vegetable.  
  Free radicals are responsible for “oxidative stress” and often are implicated in 
the expression of several human diseases including diabetes, cancer, coronary heart 
diseases, neurodegenerative ailments, rheumatoid arthritis, etc. The human body has 
an antioxidant defense system that is believed to be strengthened by antioxidant-rich 
diets. Antioxidants include β-carotene (pro-vitamin A caretonoids) and vitamin C, 
which are present in fruits and vegetables. Analyzed antioxidant activity in 35 
Ugandan fruits and vegetables and found that spider plant had an antioxidant activity 
of 0.53 to 2.92 mmol/100 g and the derived food was a major contributor to the total 
dietary antioxidant capacity in the Ugandan diet.  
High oil content in seed Seed: of spider plant has high levels of polyunsaturated oils 
that can reach up to 29.6%. The oil can be extracted by simple pressing and does not 
require refining. The seed cake can be used for animal feed, and the seed itself for 
feeding birds. 
CHEMICAL CONSTITUENTS OF CLEOME:  
  The isolation of oleic acid,   linolic acid,   palmitic acid, stearic acid,    
arachidic   acid   and    a   phytosterul from seeds   oil   of  Cleome pentaphylla Linn. 
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The root consists of two glyco-flavonones as narringenin-4-galactoside-1 and 
dihydrokaemferol-4f galactoside-2. Identification of a new glycoside-7, 3r-4-
trihydroxyflavonone-5-0-Lrhamnopyranoside-3 were reported from the whole plant of 
Cleome viscosa . Continuing their studies same workers in the same year reported the 
isolation of a new glycoside- the Cleome prenols isolated from Cleome spinosa L. 
These were identified as nonaprenol, decaprenol and undecaprenol, which are 
composed of a U terminal isoprene, three internal E-isoprene and the remaining Z-
isoprene residues respectively. S.B. Mahota and co-workers in 1979 reported the 
isolation of a novel diterpene lactone Cleomeolide -6  from Cleome icosandra Linn 
(syn Cleome viscosa Linn). From Cleome viscosa, S.K. Srivastava reported in 1980, 
the isolation of a new saponin identified as stigma-5, 24-(28) - diene-3B-0-a-L- 
rhamnoside-7. Isolation and identification of p-amyrin, lupeol, and a new glycoside 
from the roots of Cleome viscosa are also reported by the same author in the same 
year. In 1982 a Coumarinolignoid (Cleomiscosin-B) was isolated from Cleome 
viscosa seeds (by Anil L. Ray and S.K.Chattopadhyaya . In 1984 reported the 
isolation of kaempferol and luteolin-7-O-Glucoside. Some studies have been 
conducted to investigate the nutritional composition of the raw leaves of C. gynandra.  
PROPERTIES AND ACTION ACCORDING TO SIDDHA CONCEPT - 
THAIVELAI: 
 Rasa     : Katu   
Guna    : Laghu, Ruksa  
Virya    : Sita  
Vipaka : Katu 
MEDICINAL USES: 
  According to ethno-pharmacological surveys, spider plant has a number of 
medicinal uses. In Uganda, the plant is used to induce labor during childbirth. After 
giving birth, some women consume spider plant to increase lactation and blood 
formation. Spider plant remedies are used to alleviate migraine, vomiting, diphtheria, 
vertigo, headache, pneumonia, septic ears, and stomach ailments; the plant also is 
used as an eyewash and fed to boys after circumcision and 43 plants in Tanzania 
claimed to have medicinal properties and found that 37% of them had antimalarial 
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activity and some had an IC50 as low as 10 µg/mL. For spider plant, the ethyl acetate 
extract was the most effective with an IC50 obtained with 14 µg/mL. In that 
methanolic extracts of spider plant could inhibit Candida albicans and Mycobacterium 
smegmatis at 50 mg/mL and Staphylococcus aureus and Bacillus subtilis were 
susceptible to inhibition to methanolic extracts.  
  Experimental rats suffering from arthritis were administered ethanolic spider 
plant leaf extracts at a dose of 150 mg/kg of body weight for 30 days. Analysis of 
enzymes involved in the expression of arthritis showed that the rats had recovered 
from the disease and their status was comparable to the healthy control rats. The 
control of the disease was related to substances present in the leaf extracts, including 
saponins, glycosides, lectins, steroids, flavonoids, tannins, triterpens, resins, phenolic 
compounds, and arthroquinones. However, the individual involvement of these 
compounds in the control of the disease needs to be investigated. In another 
experiment administering spider plant leaf extracts to rats expressing severe arthritis, 
the analysis of lipid peroxidases, catalases, glutathione peroxidase (enzymes involved 
in the scavenging of free radicals) showed that these enzymatic activities had 
increased significantly in the diseased rats compared with the control diseased rats 
that were not fed the leaf extract treatment. On the other hand, the level of enzymes 
generating free radicals (glutathione and superoxide dismutase) was reduced 
significantly in the treated rats.  
  Free radicals also are cited as involved in the expression of plant diseases. 
Examining whether spider plant is effectively less susceptible to diseases than other 
plants (by using spider plant mutants that do not synthesize enzymes involved in the 
scavenging of free radicals) would be a useful model for plant pathologists. 
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GHEE 
GHEE: 
 Traditional system of medicine, evolved over the ages, had been completely 
looking after the healthcare of the world. Ghee is widely considered as the Indian 
name for clarified butterfat, usually prepared from cow’s milk, buﬀalo milk or mixed 
milk. Cow Ghee is a semi-liquid form of butter without water content, lactose and 
other milk solids. It is prepared by gently heating butter until it becomes a clear 
golden liquid.  Cow Ghee is light, pure and does not become rancid for a long time. 
Cow Ghee is sweet in taste, cold in nature and has a sweet after taste.  It is considered 
smoothing, soft, and oily. 
APPEARANCE OF GHEE:  
 The standard specifies ghee to have 96% minimum milk fat, 0.3% maximum 
moisture, 0.3% maximum free fatty acids (FFA) (expressed as oleic acid), and a 
Peroxide Value (PV) less than 1.0. Its physical structure should consist of a mixture of 
higher softening point fats in crystalline form dispersed in the liquid lower softening 
point fats and this gives the ghee a somewhat granular appearance. 
NUTRITIONAL ASPECTS OF GHEE: 
Ghee is a source of lipid nutrients, fat-soluble vitamins and essential fatty 
acids. About 70% of the fatty acids in milk are saturated, of which about 60% are 
long-chain fatty acids. The monoenes mainly 18:1, constitute most of the remainder, 
with thedienes and trienes together only accounting for about 3%. Although medical 
criticism has been directed at milk fat on the basis of its saturated nature, it is more 
accurate to consider it as lacking in polyunsaturates because ofitshigh18:1content. 
Debate on the role of milk fat in human health is still continuing. It suﬃces to 
highlight here, some of the alleged positive and negative aspects relevant to ghee. 
ABSORPTION OF COW GHEE:    
  Cow ghee is oil that can bond with lipid-soluble nutrients and herbs to 
penetrate the lipid-based cell walls of the body. Thus, it increases the potency of 
certain herbs by carrying the active components to the interior of the cells, which 
helps to increase Marrow, Semen & Ojas (Immunity). It is also used as a carrier of 
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nutrients to be absorbed across the cell membrane. The potency and efficiency of a 
drug is usually dependent on its  
 Ionization  
 Solubility in body fluids  
 Blood flow changes on administration   
  Sometimes a water based drug will not be able to diffuse properly in the 
cerebrospinal fluid (CSF) or other body parts. However, with Cow ghee as a solvent, 
an Ayurvedic formulation would reach the targeted areas with more efficiently. Cow 
Ghee based medicines are digested and absorbed more easily. The antioxidant 
properties of ghee help prevent damage of nervous and brain tissues besides retarding 
the progress of degenerative diseases. The cholesterol problem does not raise its ugly 
head in the administration of ghee as it is found that absorption of Cow ghee increases 
only the ‘good’ (HDL) and not the ‘bad’ cholesterol (LDL) level. This is because 
Cow ghee is capable of increasing the range of vitamins soluble in fat, like Vitamin E 
and thereby prevents the oxidation of LDL. Due to this there is no conceivable change 
in the lipid profile. All this leads to higher chances of prevention of atherosclerosis, 
stroke or heart attack.  
MEDICINAL USES OF GHEE: 
Cow Ghee is known to be digested 96% which is highest as compared to all 
other vegetable or animal source fats. It contains antioxidants like Vitamin E and beta 
carotene (600IU) besides other nutrients like phospholipids, diglycerides and 
triglycerides. It is either used as a part of a formulation as a nourishing, extracting, 
assimilating and/or absorbing agent.   Cow Ghee is an integral part of the siddha 
health science. A food that helps maintains good health, vitality and longevity. Cow 
Ghee is excellent for balancing Vata (air) and Pitta (fire) related doshas (humors). It is 
satvic (healthy) food, which has a pure influence on mind, body and spirit. Vata type 
people can enjoy more ghee than Pitta (fire) type who in turn can enjoy more ghee 
than Kapha (Water) types. Cow Ghee also brings out the aroma and flavor of many 
foods.  Cow Ghee contains no water, so it does not spoil easily and hence preserves 
the original freshness and potency of herbs and foods. Therefore, no refrigeration is 
required for Cow ghee. It is ancient siddha and folk assumption that as Cow ghee 
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becomes aged, though its taste becomes slightly bitter its effectiveness and healing 
properties increases.  
  The Cow ghee should not be administered  
 In Tuberculosis  
 Upper respiratory tract infections and bronchitis when mucous 
secretion is more   
 Indigestion, constipation, fever, diabetes. 
 Those with obesity should be very frugal in their use of ghee and those 
with high ama should not take ghee at all.  
It used for numerous medical applications, including the treatment of allergy, 
skin and respiratory diseases. Cow Ghee is also known to retard the undesirable 
effects of drugs besides cancelling the effect of toxins in the body.  
It aimed at treating ailments related to the nervous system, digestive system 
and for psychological ailments too. As  per siddha  Cow ghee is very much benifical 
to human beings It  loosen up and liquefy toxins and pacify humors (Doshas) in the 
skin and blood (called the outer disease pathway).It opens the small channels for 
dislodging and removing heavy toxins. Thus, toxins begin to drain from deeper tissues 
and start to flow in the gastro intestinal tract for elimination. It also lubricates and 
moistens the membranes and tissues. It protects tissues from damage, helps in the 
proper flowing of wastes and toxins from the body. People with a strong digestive 
power can use more ghee than those with a weak digestive system. As per siddha the 
colon is related to all other organs and tissues. When the colon is cleansed and toned 
successfully, the entire body receives healing and rejuvenation. The colon is the main 
organ through which the body absorbs nutrients thus, a proper functioning colon is 
imperative for efficient assimilation of nutrients.  Cow Ghee is beneficial & its 
benefits   are mentioned in the siddha For Example, it imparts the benefits of the best 
essential fatty acids without the problems of oxidized cholesterol, trans-fatty acids or 
hydrogenated fats. It is also resistant to free radical damage and is both salt and 
lactose free. It contains butyric acid, a fatty acid with antiviral and anti-cancer 
properties. Digestion- The siddha texts say that Cow ghee lubricates the digestive 
system and improves the digestive power because it helps enhance digestion without 
irritating the stomach and balance the stomach acids to maintain and repair the mucus 
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lining of the stomach. Cow ghee aids proper digestion and nutrient assimilation. 
People who are lactose intolerant can generally consume Cow ghee.  Cow ghee is said 
to promote all three aspects of mental functioning-- learning, memory and recall. The 
traditional texts also designate. Cow ghee - (Healthy and balanced fat in the body), 
beneficial for mental alertness and memory. It supports healthy vision, voice, 
intelligence and brain function.   
  Cow Ghee & oil are widely used in siddha system of medicine as mediums to 
administer herbal preparations. Herbs, pastes of herbs or decoction of herbs are 
infused in oil or Cow ghee and later administered to patients after diagnosing the 
condition of diseases. Cow ghee, when churned from yogurt or butter milk, it is not 
only a perfect & healthy cooking medium, but also a wonderful medicine.  
In siddha, Cow ghee is known as 'amrita'(nectar) & considered the natural oil 
for all internal body mechanisms. 
OTHER USES: 
 for body massage- apply Cow ghee all over the body, rubbing into head, 
chest, limbs, joints & orifices. It will bypass the digestive system & allow 
the qualities of Cow ghee to penetrate directly into the deeper tissues. 
Massaging the skin creates endorphins or peptides, which enhances the 
body immune system. Regular slows the aging process. 
 Cow Ghee is used in purvakarma (early panchkarma), where the small 
amount of Cow ghee is taken first thing in the morning by the practitioner 
to oleate the internal organs & dissolve the ama or toxic wastes in the 
tissues, allowing them to be to be carried to the digestive tract for 
elimination. 
 Cow Ghee is used as a carrier for herbs and its supreme penetrating 
qualities and thus ability to carry these substances deep into the tissues. 
 One or two teaspoons first thing in the morning followed immediately with 
hot water produce a bowel movement. Two spoon full of Cow ghee in 
warm milk before bedtime soothing to the nerves and lubricates the 
intestines and facilitates the bowel movement in the morning. 
 In ancient India Cow ghee used for recovery from wounds. It can be 
applied on broken bones & bruises & effective against skin rashes.  
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 Cow Ghee is excellent for scrapes & both type of  burns i.e. fire or 
chemicals. 
 Cow Ghee is excellent for a gargle, to improve the health of the teeth & 
gums. 
 Cow Ghee can be used as a bath oil & an exquisite facial moisturizer. 
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DRUG PAVALAPARPAM  PROCESS 
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PAVALA PARPAM 
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4. MATERIALS AND METHODS 
 
PREPARATION OF MEDICINE: 
 
Selection of Drug 
 ‘PAVALA PARPAM’ as mentioned in the text Kannusamy Parambarai 
vaithiyam, Pg.385,386  was choosen. 
 
Ingredients: 
• Purified PAVAZHAM -  2palam   (70gm) 
• Thai Velai  Leaf  Karkam 
 
PURIFICATION OF RAW DRUG : 
Pavazham is soaked in lime juice for one day and it is washed with hot water. 
 
METHOD OF PREPARATION: 
Step 1 :  
Thai velai leaf is made into karkam, and then it is kept on sunlight.  
Step  2 :  
  2 Palam of purified pavazham is kept inside the karkam and closed.  
Step 3 :  
  And then it is closed with earthern saucer with mud and dried. Then it is 
cupellated with 40-50 cow dung cake to get the parpam. 
DOSE : 
 ½ - 1 Kuntri Edai 
Adjuvant : 
Ghee or Honey 
Indication: 
  It is being used for Eelai, Shayam, Megasoodu, Dega varatchi, Erumal. 
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QUALITATIVE AND QUANTITATIVE ANALYSIS 
PHYSICOCHEMICAL ANALYSIS 
 
 Sample Description  : PAVALA PARPAM 
 Equipment used  : Atomic Absorption Spectrometer (AAS) 
 
Colour: 
 About 50gm of PAVALA PARPAM was taken in a clean glass beaker and 
tested for its colour by viewing again a water opaque background under direct 
sunlight. 
 
pH: 
 The pH of PAVALA PARPAM was estimated as per the method prescribed in 
Indian Standard (IS) – 6940 (1982). One gram of the PAVALA PARPAM  was taken 
into a 100ml graduated cylinder containing about 50ml of water and filled up to the 
mark with water. The cylinder was stopped and shaken vigorously for two minutes 
and the suspension was allowed to settle for an hour at 250 to 270.  About 25ml of the 
clear aqueous solution was transferred into a 50ml breaker and tested for pH using 
DIGISUN digital pH meter ( DIGISUN Electronics, Hyderabad, India) 
 
Determination of Ash Value: 
 Weighed accurately 2 grams of PAVALA PARPAM in tarred platinum or 
silica dish and incinerate at a temperature not be exceeding 4500C until free from 
carbon, cooled and weighed. Calculate the percentage of ash with reference to the air 
dried drug. 
 
Water Soluble Ash: 
 To the gooch crucible containing to the total ash, added 25ml of water and 
boiled for 5 minutes. Collected the insoluble matter in a sintered glass crucible or on 
ash less filter paper. Wash with hot water and ignite in a crucible for 15 minutes at a 
temperature nor exceeding 4500 C  subtract the weight of the insoluble matter from 
the weight of the ash the difference of the weight represents the water soluble ash. 
Calculate the percentage of water soluble ash with reference to the air dried drug. 
 
 
45 
 
Acid Insoluble Ash: 
 Boiled the ash 5 minutes with 25ml of 1:1 dil HCL. Collect the insoluble 
matter in gooch crucible on an ash less filter paper wash with hot water and ignite. 
Cooled in a desiccators and weighted calculated the percentage of acid insoluble ash 
with reference to the air dried drug. 
 
Loss on Drying: 
 Five grams of PAVALA PARPAM is heated in a hot oven at 1050C to constant 
weight and the percentage of loss of weight has calculated there from. 
  FOURIER TRANSFORM 
PERKIN ELMER 
 
FOURIER TRANSFORM 
PERKIN ELMER 
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Introduction 
 Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular  structure. The spectral bands can be assigned to different vibrational 
modes of the molecule. The various functional groups present in the molecule can be 
assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular interactions, 
phase transitions and chemical kinetics can be carried out using this branch of 
spectroscopy. 
 In IR spectroscopy, the resonance absorption in made possible by the change 
in dipole moment accompanying the vibrational transition. The infrared spectrum 
originates from the vibrational motion of the molecule. The vibrational frequencies 
are a kind of fingerprint of the compounds. This property is used for characterization 
organic, inorganic and biological compounds. The band intensities are proportional to 
the concentration of the compound and hence qualitative estimations are possible. The 
IR spectroscopy is carried out by using Fourier transform technique. 
Principle 
 Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction,l electromagnetic radiation characteristic 
of the interacting system may be absorbed (or emitted). The experimental data consist 
of the nature (frequency of wave length) and the amount (intensity) of the 
characteristic radiation absorbed or emitted. These data are correlated with the 
molecurlar and electronic structure of the substance and with intra – and inter 
molecular interactions. 
 FT-IR spectroscopy is used primarily for qualitative and quantitative analysis 
of organic compounds, and also for determining the chemical structure of inorganic 
materials. The region between 500-4000 wave number is referred to as the finger print 
region. Absorption bands in this region are generally due to intra molecular 
phenomena and are highly specific for each material. The specificity if these bands 
allow computerized data searches to be performed against reference libraries to 
identify a material. 
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Table of Characteristic IR Absorptions 
Frequency, cm-1 Bond Functional group 
3640 - 3610 (s, sh) O-H stretch Free hydroxyl alcohols phenols 
3500 - 3200 (s,b) O-H stretch, H – bonded Alcohols, phenols 
3400 – 3250 (m) N – H stretch Primary, secondary, amines, 
amides 
3300 – 2500 (m) O – H stretch Carboxylic acids 
3330 -  3270 (n, s)  –C (triple bond) C – H : C  - H 
stretch 
Alkynes (terminal) 
3100 – 3000 (s) C – H stretch Aromatics 
3100 – 3000 (m) = C – H stretch Alkenes 
3000 – 2850 (m) C – H stretch Alkenes 
2830 – 2695 (m) H – C = 0; C –H stretch  Aldehydes 
2260 -  2210 (v) C (triple bond) N stretch Nitriles 
2260 – 2100 (w) C (triple bond) C- stretch Alkynes 
1760 – 1665 (s) C = 0 stretch Carbonyls (general) 
1760 – 1690 (s) C = 0 stretch Carboxylic acids 
1750-  1735 (s) C = 0 stretch Esters, saturated aliphatic 
1740 – 1720 (s) C = 0 stretch Aldehydes, saturated aliphatic 
1730 – 1715 (a) C = 0 stretch Alpha, beta – unsaturated esters 
1715 (s) C = 0 stretch Ketones, saturated aliphatic 
1710 – 1665 (s) C = 0 stretch Alpha, beta – unsaturat 
aldehydes, ketones 
1680 – 1640 (m) -C = C - Alkenes 
1650 – 1580 (m) N – H bend Primary amines 
1600 – 1585 (m) C-C stretch (in – ring) Aromatics 
1550 – 1475 (s) N – 0 asymmetric stretch Nitro compounds 
1500 – 1400 (m) C –C stretch (in – ring) Aromatics 
1470 – 1450 (m) N – 0 asymmetric stretch Nitro compounds 
1370 – 1350 (m) C – H bend Alkanes 
1360 – 1290 (m) C – H rock Alkanes 
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1335 – 1250 (s) C – N stretch Aromatic amines 
1320 – 1000 (s) C – 0 stretch Alcohols, carboxylic acids, 
esters, ethers 
1300 – 1150 (m) C – H wag ( - CH2X) Alkyl halides 
1250 – 1020 (m) C – N stretch Aliphatic amines  
1000 – 650 (s) =C – H bend Alkynes 
950 – 910 (m) O – H bend Carboxylic acids 
910 – 665 (s, b) N – H wag Primary, secondary amines 
900 – 675 (s) C – H “oop” Aromatics 
850 – 550 (m) C – CI stretch Alkyl halides 
725 – 720 (m) - C (triple bond) C-H : C- H 
bend 
Alkynes 
690 – 515 (m) C  - Br stretch Alkyl halides 
 
M = medium, w = weak, s=strong, n =  narrow, b = broad, sh = sharp 
 
Sampling techniques: 
 There are a variety of techniques for sample preparation depending on the 
physical form of the sample to be analyzed. 
 Solid : KBr or Nujol mull method 
 Liquid : CsI / TIBr Cells 
 Gas : Gas Cells 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai – 36KBr Method 
 The Sample was grounded using – an agate mortar and pestle to give a very 
fine powder. 
 The finely powder sample was mixed with about 100 mg dried KBr salt. 
 The mixture was then pressed under hydraulic press using a dye to yield a 
transparent disc (measure about 13 mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed.  
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HR SEM - METHODOLOGY 
 
 
HR SEM-Methodology: 
 An SEM is essentially a high magnification microscope, which used a focused 
scanned collection beam to produce images of the sample, both top-down and, with 
the necessary sample preparation, cross-sections. The primary electron beam interacts 
with the sample in a number of key ways:- 
Primary electrons generate low energy secondary electrons, which tend to emphasize 
the topographic nature of the specimen. 
  Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast. 
  Ionized atoms can relax by electron shell-to-shell transitions. Which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few urn of the sample. 
 
Sample Preparation: 
 Sample preparation can be minimal or elaborate for SEM analysis depending 
on the nature of the samples and the data required. Minimal preparation includes 
acquisition of a PAVALA PARPAM that will fit into the SEM chamber. And it should 
be analyzed. 
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INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP-OES), 
 
 
Fig. 5: ICPOES  Apparatus  
 
ICP OES METHODOLOGY: 
 ICP, abbreviation for Inductively Coupled Plasma, is one method of optical 
emission spectrometry, When plasma energy is given to an analysis sample from 
outside, the component elements (atoms) is excited. When the excited atoms return to 
low energy position, emission rays that correspond to the photon wavelength are 
measured. The element type is determined based on the position of the photon rays, 
and the content of each element is determined based on the ray’s intensity. 
 To generate plasma, first, argon gas is supplied to torch coil, and high 
frequency electric current is applied to the work coil at the tip of the torch tube. Using 
the electromagnetic field created in the torch tube by the high frequency current, 
argon gas in ionized and plasma is generated. This plasma has high electron density 
and temperature (10000K) and this energy is used in the excitation –emission of the 
sample. Solution samples are introduced into the plasma in an atomized state through 
the narrow tube in the center of the torch tube. 
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Sample preparation: 
  Solids cannot be analyzed directly. Such samples should be made into clear 
aqueous medium quantitatively. When acids are used to prepare solutions care should 
be taken. The concentration of the acids in the final provided solution should not be 
more than 2% v/v. highly acidic and organic solutions cannot be analyzed. As a guide 
line weigh exactly, around 200mg of substance and dissolve in 5mL of 5% of water or 
aquaregia or whatever acid to make 100mL of final solution. Make proper dilutions, if 
necessary. Free HF should not present in the final solution to be aspirated. 
  Ideal concentration is around 100 ppm of the element of interest. Total 
dissolved solids should be not more than 0.2% w/v in the final solution Very dilute 
solution may not give reliable results. Each element has a detection limit. A minimum 
solution volume of 25 ml is necessary for analysis. 
In ICP intensity of light emitted when the sample “sprayed or aspirated into an 
argon plasma” is measured at different wavelengths. The intensity of light at a given 
wavelength will be proportional to a particular elemental ion concentration. The 
intensity is calibrated with known standard concentration. For accurate quantitative 
results It is necessary to simulate the sample matrix condition with that of the 
standard. Each element generally will have many emission lines and the sensitivity is 
different for each of this wave length. When more than one element is present it is 
quite common that some emission lines interfere due to overlapping. 
  It is preferable to use plastic containers for sample handling and preserving 
samples for ICP-OES analysis. Glass containers can give problems especially when 
analyzing certain metal ions at low concentration. 
  The samples of  PAVALA PARPAM was prepared. 
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6. PRECLINICAL STUDY 
ACUTE TOXICITY STUDY IN FEMALE WISTAR ALBINO RATS TO 
EVALUATE TOXICITY PROFILE OF PAVALA PARPAM 
 
OBJECTIVES 
 The aim of this study is to evaluate the toxicity of the test substance PAVALA 
PARPAM , when administered orally to Female Wistar Albino Rats with different 
doses, so as to provide a rational base for the evaluation of the toxicological risk to 
man and indicate potential target organs. 
 
Guidelines followed: 
 OECD Guidelines No.423 
 The experimental protocol was approved by Institutional Animal Ethical 
Committee as per the guidance of Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and 
Forest, Government of India. 
 
Study design and Controls: 
1) Female Wistar Albino Rats in controlled age and body weight were selected. 
2) PAVALA PARPAM  was administered at 5mg/kg, 50mg/kg, 300mg/kg, 2000 
mg/kg body weight as (Water) as suspension along with blank. 
3) The results were recorded on the day of drug administration approximately 1st, 
3rd , 4th and 24th  hour in post dosing and further made into observation upto 14 
days. 
 
EXPERIMENTAL PROCEDURE 
1.Animals 
1.1.Supply 
 A total of 15 Female Wistar Albino Rats with an approximate age of 6 weeks 
are purchased from JAWAHARLAL INSTITUTE OF POSTGRADUATE 
MEDICAL EDUCATION AND RESEARCH, PUDUCHERRY-6. On their arrival, a 
sample of animals was chosen at random and weighted to ensure compliance with the 
age requested. The mean weights of Female Wistar Albino Rats were 100 – 150g 
respectively. The animals were housed in metabolic cages (55 X 32.7 X 19 cm), with 
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sawdust litter, in such a way that each cage contained a maximum of 3 rats of the 
same sex. 
 All animals underwent a period of 14 days of observation and acclimatization 
between the date of arrival and the start of treatment. During the course of this period, 
the animals were inspected by a veterinary surgeon to ensure that they fulfilled the 
health requirements necessary for initiation of the study. 
 
1.2. Housing 
 The Female Wistar Albino Rats were housed in metabolic cages (55 X 32.7 X 
19 cm), placed on racks. From the week before initiation of the treatment, each cage 
contained a maximum of 3 rats of the same sex and treatment group. 
 Each cage was identified by a card, color coded according to the dose level. 
This card stated the cage number, number and sex of the animals it contained, Study 
number, test substance code, administration route, dose level and study drugs name, 
date of the arrival of the animals and initiation of treatment. 
 The temperature and relative humidity were continuously monitored. Lighting 
was controlled to supply 12 hours of light ( 7:00 to 19:00 hours) and 12 hours of dark 
for each 24 hour period. 
  The animals were kept in a clean environment with 12 hour light and 12 hour 
dark cycles. The air was conditioned at 22±3°C and the relative humidity was 
maintained between 30 – 70% with 100% exhaust facility. 
 The cages corresponding to each experimental group were distributed on racks 
in such a manner that external factors, such as environmental conditions, were 
balanced as far as possible. 
2.Diet 
 All the rats had free access to a pelleted rat diet. The diet was analyzed by the 
manufacturer to check its composition and to detect possible contaminants. 
2.1. Water 
 The water was offered ad libitum in bottles. 
3.Administration Route and Procedure 
 The test substance was administered orally. The Female Wistar Albino Rats 
belonging to the control group were treated with the vehicle(Water) at the same 
administration volume as the rest of the treatment groups. 
The animals were marked on body with picric acid solution prepared in water.  
The marking within the cage was as below. 
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Table-1 Grouping and Marking of Animals 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
  The group number, cage number, sex of the animal and animal number were 
identified as indicated below using cage label and body marking on the animals. 
Table – 2 Numbering and Identification 
Cage No Group No Animal marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
 
3.1. Doses: 
 The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighted and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
Table – 3. Doses 
GROUP DOSE 
Group –I Control 
Group – II 5mg/kg 
Group – III 50mg/kg 
Group – IV 300mg/kg 
Group – V 2000mg/kg 
 
 The test substance was administered as single dose. After single dose 
administration period, all animals were observed for 14 days. 
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3.2. Dose Preparation 
 PAVALA PARPAM was added in distilled water and completely dissolved to 
oral form for administration. The dose was prepared for a required concentration 
before dosing by dissolving in distilled water. It was mixed well. The preparation for 
different doses was vary in concentrations to allow a constant dosage volume. 
 
3.3. Administration 
 The test substance was administered orally to each female Wistar Albino rats 
as single dose using a needle [straight, 10guage, 5.9 inches (15.2cm) length, 6.4mm 
tip] fitted onto a disposable syringe of appropriate size at the following different 
doses. The concentration was adjusted according to its body weight. The volume was 
not exceeding 10ml/kg bodyweight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
 
3.4. Observation period 
 All animals were observed for any abnormal clinical signs and behavioral 
changes. The appearance, change and disappearance of these clinical signs, if any, 
were recorded for approximately 1.0, 3.0, 4.0 and 24.0 hours post-dose on day of 
dosing and once daily thereafter for 14 days. Animals in pain or showing severe signs 
of distress were humanely killed. The cageside observation includes changes in skin, 
fur, eyes and mucous membranes, occurrence of secretions and excretions. 
Autonomic activity like lacrimation, piloerection, pupil size and unusual respiratory 
pattern, changes in gait, posture, response to handling, presence of clonic or tonic 
movements, stereotypes like excessive grooming and repetitive circling or bizarre 
behavior like self – mutilation, walking backwards etc were observed. At the 14th day, 
sensory reactivity to stimuli of different types (e.g: auditory, visual and proprioceptive 
stimuli) was conducted. Auditory stimuli responses were measured by clicker sound 
from approximately 30cm to the rats; Visual stimuli response were measured with the 
help of shining pen light in the eye of rats and placing a blunt object near to the eye of 
rats. Response to proprioceptive stimuli was measured by placing anterior/dorsal 
surface of animals paw to the table edge. The responses of reactions for these three 
exercises were normal in animals belonging to both the controls as well as drug 
treatment dose groups. 
 
4.0 Mortality and Morbidity 
 All animals were observed daily once for mortality and morbidity at 
approximately 1.0, 3.0, 4.0 and 24.0 hours post dose on day of dosing and twice daily 
(morning and afternoon) thereafter for 14 days. 
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SUB-ACUTE TOXICITY STUDY IN WISTAR ALBINO RATS TO 
EVALUATE TOXICITY PROFILE OF PAVALA PARPAM  
1.Objective 
 The objective of this ‘Sub-acute toxicity study of PAVALA PARPAM on 
Wistar Albino Rats’ was to assess the toxicological profile of the test item when 
treated as a single dose. Animals should be observed for 28 days of drug 
administration. This study provides information on the possible health hazards likely 
to arise from exposure over a relatively limited period of time. 
 
2. Test Guideline followed 
 OECD 407 Method – Sub-Acute Toxic Class Method (Repeated Dose 28-Day 
Oral Toxicity Study in Rodents) 
 
3. Test Substance Detail 
 Name : PAVALA PARPAM  
 
4. Test System Detail 
 The study was conducted on 3 male and 3 female Wistar Albino Rats. These 
animals were selected because of the recommended rodent species for oral studies as 
per followed guideline and availability of animals 6 weeks old male and female rats 
were selected after physical and behavioral examination. The body weight range was 
fallen within ± 20% of the mean body weight at the time of randomization and 
grouping. The rats were housed in standard laboratory condition in Polypropylene 
cages, provided with food and water ad libitum. The experimental protocol was 
approved by Institutional Animal Ethical Committee as per the guidance of 
Committee for the Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA), Ministry of Environment and Forest, Government of India. 
 
 
5.Acclimatization 
 The animals were selected after veterinary examination by the Veterinarian. 
All the selected animals were kept under acclimatization for a week. 
 
6.Randomization & grouping 
 One day before the initiation of treatment (days 0- last day of acclimatization), 
the selected animals were randomly grouped into four different groups containing 
minimum   6 animals (3 Male + 3 Female) per group. 
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7. Numbering and Identification 
 The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
Table-4  Animal Identification 
Group No Animal marking 
Control H,B,T, E, L, NM 
Low dose  H,B,T, E, L, NM 
Mid dose  H,B,T, E, L, NM 
High dose  H,B,T, E, L, NM 
 
 The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage label and body marking on the animals. 
 
Table-5  Animal Marking 
Cage no Group no Animal marking Sex 
1 Control 
H, B,T Male 
E, L, NM Female 
2 Low dose 
H, B,T Male 
E, L, NM Female 
3 Mid dose 
H, B,T Male 
E, L, NM Female 
4 High dose 
H, B,T Male 
E, L, NM Female 
H – Head,  B – Body,  T – Tail, E- Earlobe, L – Limb,  NM – No Marking 
 
8. Husbandry 
8.1. Housing 
 The Wistar Albino Rats were housed in standard polypropylene cages with 
stainless steel top grill. Paddy husk was used as bedding. The paddy husk was 
changed at least twice in a week. From the week before initiation of the treatment, 
each cage contained a maximum of 3 rats of the same sex and treatment group. 
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8.2. Environmental conditions 
 The animals were kept in a clean environment with 12 hour light and 12 hour 
dark cycles. The air was conditioned at 22±3°C and the relative humidity was 
maintained between 30 – 70% with 100% exhaust facility. The cages corresponding 
to each experimental group were distributed on racks in such a manner that external 
factors such as environmental conditions were balanced as far as possible. 
 
8.3 Feed & feeding schedule 
 Feed was provided ad libitum throughout the study period, except over night 
fasting (18-20 hours) prior to dose administration. After the substance has been 
administered, food was with held for a further 3-4 hours. 
 
8.4 Water 
 The water was offered ad libitum in bottles. They were periodically analyzed 
to detect the presence of possible contaminants. 
 
8.5 Doses 
 The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then test 
substance was administered orally as single dose using a needle fitted onto a 
disposable syringe of approximate size at the following different doses. 
 
Table – 6 Dose level 
TEST GROUP 
DOSE TO ANIMALS (mg/kg 
body – weight/day) 
NUMBER OF 
ANIMALS 
Group – I Control 6(3male and 3female) 
Group – II 
Low dose of PAVALA PARPAM                         
(5mg/ Kg) 
6(3male and 3female) 
Group – III 
Mid dose of PAVALA PARPAM 
(10mg/ Kg) 
6(3male and 3female) 
Group – IV 
High dose of PAVALA PARPAM 
(20mg/ Kg) 
6(3male and 3female) 
 
 The test substance was administered as single dose for 28 days and all animals 
are observed . 
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8.5 a. Dose preparation 
 PAVALA PARPAM was added in distilled water and completely dissolved to 
for oral for administration. The dose was prepared of a required concentration before 
dosing by dissolving PAVALA PARPAM in distilled water. It was mixed well. The 
preparation for different doses was vary in concentrations to allow a constant dosage 
volume. 
 
8.6. Administration 
 The test substance was administered orally to each rat as single dose using a 
needle fitted onto a disposable syringe of appropriate size at the following different 
doses. The concentration was adjusted according to its body weight. The volume was 
not exceeding 10ml/kg body weight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
 
9. Observation 
 These observations were also performed on week – ends. The observations 
included but were not limited to changes in skin, fur, eyes, mucous membranes, and in 
the respiratory, circulatory, central nervous, autonomous systems, somatomotor 
activity and behavior. 
 
9.1. Clinical signs of toxicity 
 All the rats were observed atleast twice daily with the purpose of recording 
any symptoms of ill-health, behavioral changes and clinical signs of toxicity daily for 
28 days. 
 
9.2. Food intake 
 Prior to the beginning of treatment and daily food intake of each cage was 
recorded for period of 28 days and the mean weekly intake per rats was calculated. 
 
9.3 Water intake 
 Water intake was checked by visual observation during the study. In addition, 
the water consumption in each cage was measured daily for a period of 28days. 
 
9.4 Body weight 
 The body weight of each rat was recorded one week before the start of 
treatment, and during the course of the treatment on the day of initial, 7th, 14th , 21st  
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and 28th day. The mean weight for the different groups and sexes were calculated 
from the individual weight. 
 
Blood collection 
 Blood was collected through retro – orbital sinus from all the animals of 
different groups on 29th day. The blood was collected in tubes containing 
Heparin/EDTA as an anticoagulant. Animals were fasted over night prior to the blood 
collection. 
 
LABORATORY STUDIES 
 After the 4th week of treatment, samples of blood were withdrawn from the 
orbital sinus from each group, under weak ether anesthesia after fasting for 16 hours. 
The blood samples are used to evaluate Hematological parameters like RBC, WBC, 
Hb% and DC. The collected blood samples also centrifuged 10000rpm in 10 minutes 
to separate the serum. The separated serum used to evaluate biochemical parameters 
like SGOT, SGPT, ALP, UREA and CREATININE etc. 
 
Hematology 
 The following hematological parameters were analysed using Autoanalyser 
  Hb  : Haemoglobin(gm%) 
  WBC  : White Blood Corpuscles (x103/cu.mm) 
  RBC  : Red Blood Corpuscles (x106/cu.mm) 
 Differential count: 
  N  : Neutrophils (%) 
  L  : Lymphocytes (%) 
  M  : Monocytes (%) 
  E  : Eosinophils (%) 
  B  : Basophils (%) 
Clinical biochemistry: 
 The following clinical Bio-chemical parameters were analysed using Auto 
analyser 
  ALT/SGPT  : Alanine amino transferase (U/L) 
  AST/SGOT  : Aspartate amino transferase (U/L) 
  ALP   : Alkaline serum phosphatase (U/L) 
  SERUM UREA (mg/dl) 
  SERUM CREATININE ( mg/dl) 
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Terminal studies 
Sacrifice and macroscopic examination 
 On completion of the 28 days of treatment,  Wistar Albino Rats were 
sacrificed by ether inhalation. A full autopsy was performed on all animals which 
included examination of the external surface of the body, all orifices, cranial, thoracic 
and abdominal cavities and their contents both in situ and after evisceration. As the 
number of animals exceeded the number that could be sacrificed in one day, the 
autopsies were carried out over three consecutive days at the end of the treatment 
period. 
Organ weights: 
 After the macroscopic examination the following organs were weighed after 
separating the superficial fat: Heart, Kidneys and Liver. 
 
HISTOPATHOLOGICAL STUDIES 
 Anatomy of the liver was studied immediately after sacrificing the animals. A 
small portion was fixed in 10% neutral buffered formalin as described by Luna 14. 
Thin sections of 4-5µm were taken, stained with Haematoxylin and Eosin and 
histology was studied. 
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RESULTS 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
Table -7 
Colour characters of PAVALA PARPAM 
No Nature of drug Nature of colour 
1 PAVALA PARPAM White 
 
Table 8— Physicochemical analysis of samples of PAVALA PARPAM  
[Values are mean of three determinations ±SEM] 
Parameters Total ash Values 
Ash value 
Water soluble ash 
Acid insoluble ash 
7.75±0.011 
0.95±0.011 
Extractive value Water soluble extractive value 8.20±0.310 
Loss on drying Loss on drying at 70°C 8.30±0.240 
 
SEM- singularity expansion method 
Table-9 
Particle size and pH of PAVALA PARPAM 
S.No Parameters Values obtained 
1 Particle size by SEM 2-1 µ 
2 pH 8.751 
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PAVALA PARPAM (FTIR METHOD) 
 
 
Pavala Parpam 
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PAVALA PARPAM 
Table – 10 of characteristic IR Absorptions 
 
Inference :  
  The PAVALA PARPAM contains, Aromatic compounds, Alkynes, Alkene, 
Alkyl halide, Alcohal, Acyl chloride, Esters, Carboxylic acids, Amides, Amines. 
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SEM ANALYSIS 
Scanning Electron Microscope (SEM) 
 
SEM -20000 Magnification 
    
SEM -30000 Magnification 
 
Results and Interpretation of SEM analysis: 
   The morphology of the PAVALA PARPAM sample can be determined by 
SEM (FEI Quanta). A representative portion of each sample must be  sprinkled onto a 
double side carbon tape and mounted on aluminium stubs, in order to get a higher 
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quality secondary electron image for SEM examination. We have observed from SEM 
photographs that particles are spherical in shapes and sizes are in the range from                 
2 - 1 micron.   Although the particle sizes of different batches showed similarity, it 
seems that these particles are aggregates of much smaller particles. When dispersed in 
an aqueous medium, these preparations form a negatively charged hydrophobic 
particle suspension. This hydrophobicity gives these particles a tendency to aggregate 
together to form larger particles. PAVALA PARPAM exhibited larger sizes and 
agglomeration of the particles. Therefore, the comparatively larger size may be due to 
the agglomeration of the particles by repeated cycles of calcinations involved in 
preparation. 
  
68 
 
SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM, CHENNAI-36 
PERKIN ELMER OPTIMA 5300 DV ICP-OES 
  
Sample ID                                  Elements Symbol                   Concentration 
                                                    Wavelength (nm)  
Pavala Parpam    (wt:0.41210g)  
 
Al  396.152                   BDL 
As  188.979  BDL 
Ba  455.403                                05.221 mg/L 
Ca  315.807  881.100 mg/L 
Cd  228.802   BDL 
Cu  327.393  BDL 
Hg  253.652  BDL 
K  766.491  03.171 mg/L 
Mg  285.213  01.784 mg/L 
Na  589.592  02.280 mg/L 
Ni  231.604  BDL 
Pb  220.353  BDL 
P  213.617  126.227 mg/L 
Sr  421.502  03.654 mg/L 
S  180.731  11.324 mg/L 
 
BDL- Below detection limit 
 
PAVALA PARPAM contains Aluminium, Arsenic, Cadmium, Copper, Mercury, 
Nickel, Lead are in below detection limit. 
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RESULTS: 
 
PH range :  8.751 
FTIR data :  PAVALA PARPAM contains  Aromatic compounds, Alkynes,  
Alkene,  Alkyl halide, Alcohal, Acyl chloride, Esters, 
Carboxylic acids, amides and amines. 
HR SEM    :  PAVALA PARPAM has the particle size in the range of   
2-1 micron  
ICP-OES data :  PAVALA PARPAM shows Aluminium, Arsenic, Cadmium,  
Copper, Mercury, Nickel and Lead are in below detection limit. 
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BIO-CHEMICAL ANALYSIS OF PAVALA PARPAM 
Preparation of the extract:   
  100mgs of parpam is weighted accurately and placed into a clean beaker and 
added a few drops of Conc.  Hydrochloric acid and evaporated it well. After 
evaporation cooled the content and added a few drops of conc. nitric acid and 
evaporated it well. After cooling the content  add 20ml of distilled water and 
dissolved it well. Then it is transferred to 100ml volumetric flask and made up to 
100ml with distilled water, mix well, filter it. Then it is taken for analysis. 
Table - 11 
BIO-CHEMICAL ANALYSIS  
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  
TEST FOR CALCIUM 
2ml of the above prepared extract is taken 
in a clean test tube. To this add 2ml of 4% 
Ammonium oxalate solution 
A white precipitate is 
formed 
Indicates the 
presence of 
calcium 
2. 
TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
chloride solution. 
A white precipitate is 
formed 
Indicates the 
presence of 
sulphate 
3.  
TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution 
A white precipitate is 
formed 
Indicates the 
presence of 
chloride 
4. 
TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
A Brisk 
effervessence is 
formed 
Indicates the 
presence of 
carbonate 
5. 
 
TEST FOR STARCH 
The extract is added with weak iodine 
solution 
No Blue colour is 
formed 
Absence of 
starch 
6.  
TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro cyanide. 
 
No blue colour is 
formed 
Absence of ferric 
iron 
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7. 
TEST OF FERROUS IRON  
The extract is treated with concentrated 
Nitric acid and Ammonium thio cyanate 
solution 
Blood red colour is 
formed 
Indicates the 
presence of 
ferrous iron 
8.  
TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow 
precipitate is formed 
Absence of 
phosphate 
9.  
TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No Yellow 
precipitate is formed 
Absence of 
Albumin 
10.  
TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
No Blue black 
precipitate is formed 
Absence tannic 
acid 
11.  
TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It doesnot  gets 
decolourised. 
 
Absence of 
unsaturated 
compound 
12.  
TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 
2 mts and add 8-10 drops of the extract 
and again boil it for 2 mts. 
No colour change 
occurs. 
Absence of 
Reducing sugar 
13.  
TEST FOR AMINO ACID 
One or two drops of the extract is placed 
on a filter paper and dried well. After 
drying, 1% Ninnhydrin is sprayed over 
the same and dried it well. 
No Violet colour is 
formed 
Absence of 
Amino acid 
14. 
TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white precipitate 
is formed 
Absence of Zinc. 
 
Inference: 
  Analysis reveals the presence of Calcium, Sulphate, Chloride, Carbonate, 
Ferrous iron in PAVALA PARPAM . 
  Biochemical Analyis report was given by Mrs. N.Nagaprema, M.Sc., H.O.D, 
Bio Chemical Department, Government Siddha Medical College, Palayamkottai. 
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EFFECT OF ACUTE TOXICITY (14 DAYS) OF PAVALA PARPAM  
Table - 12 Physical and behavioral examinations. 
Group no. Dose(mg/kg) Observation sign No. of animal 
affected. 
Group-I Control Distilled 
water (1ml/kg) 
Normal 0 of 3 
Group- II 5mg/kg Normal 0 of 3 
Group-III 50mg/kg Normal 0 of 3 
Group-IV 300mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
 
Table- 13 Showed the effect of  Control – Distilled water (1ml/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior 
Time of observation after Control - Distilled 
water (1ml/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
‘+’ PRESENT & ‘-‘ ABSENT 
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Table - 14 Showed the effect of PAVALA PARPAM  (5mg/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior Time of observation after PAVALA PARPAM  
(5mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table - 15 Showed the effect of PAVALA PARPAM  (50mg/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior Time of observation after PAVALA PARPAM  
(50mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table - 16 Showed the effect of PAVALA PARPAM  (300mg/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior Time of observation after PAVALA PARPAM  
(300mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table  - 17  Showed the effect of PAVALA PARPAM  (2000mg/kg) on general 
behavior after single oral administration in Rat. 
SI.NO General Behavior Time of observation after PAVALA PARPAM  
(2000mg/kg) administration 
1st Hr 3rd Hr 4th Hr 24th Hr 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity + - - ++ 
8 Muscle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consistency - - - - 
 
‘+’ PRESENT & ‘-’ ABSENT 
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Table - 18 Home cage activity 
Functional and 
Behavioral 
observation 
Observation 
Control 
Distilled 
water 
(1ml/kg) 
5mg/kg 
Group 
(G-II) 
50mg/kg 
(G-III) 
300mg/kg 
(G-IV) 
 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 
Approach 
response 
Normal 3 3 3 3 3 
Touch response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tailpinch response Normal 3 3 3 3 3 
 
Table  - 19  Hand held observation 
Functional and 
Behavioral observation 
O
bs
er
v
a
tio
n
 Control 
Distilled 
water 
(1ml/kg) 
5 
mg/ kg 
(G-II) 
50 
mg/kg 
(G-II) 
300 
mg/kg 
(G-III) 
2000 
mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 
Handling Normal 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 
Pupillary reflex Normal 3 3 3 3 3 
Abdominal tone Normal 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 
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Table - 20 Mortality 
Group no Dose  level (mg/kg) Mortality 
Group-I 
Control 
[Distilled water (1ml/kg)] 
0 of 3 
Group-II 5(mg/kg) 0 of 3 
Group-III 50(mg/kg) 0 of 3 
Group-IV 300(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
Result: 
 From acute toxicity study it was observed that the administration of PAVALA 
PARPAM up to the dose of 2000mg/kg to the rats do not produce drug-related 
toxicity and mortality. So No-Observed-Adverse-Effect-Level(NOAEL) of PAVALA 
PARPAM is 2000mg/kg. 
 
DISCUSSION 
 PAVALA PARPAM was administered single time at the dose of 5mg/kg, 
50mg/kg, 300mg/kg and 2000mg/kg to rats and observed for consecutive 14 days 
after administration. Doses were selected based on the pilot study and literature 
review. All animals were observed daily once for any abnormal clinical signs. Weekly 
body weight and food consumption were recorded. No mortality was observed during 
the entire period of the study. Data obtained in this study indicated no significance 
physical and behavioral signs of any toxicity due to administration of PAVALA 
PARPAM at the doses of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rat. 
 At the 14th day, all animals were observed for functional and general 
behavioral examination. In functional and general behavioral examination, home cage 
activity, hand held activity were observed. Home cage activities like Body position, 
Respiration, Clonic involuntary movement, Tonic involuntary movement, Palpebral 
closure, Approach response, Touch response, Pinna reflex, Sound responses, Tail 
pinch response were observed. Handheld activities like reactivity, Handling, Palpebral 
closure, Lacrimation, Salivation, Piloerection, Papillary reflex, abdominal tone, Limb 
tone were observed. Functional and general behavioral examination was normal in all 
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treated groups. Food consumption of all treated animals was found normal as 
compared to normal group. 
 Body weight at weekly interval was measured to find out effect of PAVALA 
PARPAM on the growth rate. Body weight change in drug treated animals was found 
normal. 
 
SUMMARY & CONCLUSION 
Summary: 
 The present study was conducted to know single dose toxicity of PAVALA 
PARPAM on female Wistar Albino Rats. The study was conducted using 15 female 
Wistar Albino Rats. The female animals were selected for study of 8-12 weeks old 
with weight range of within ±20% of mean body weight at the time of randomization. 
The groups were numbered as group I, II, III, IV and V and dose with 5mg/kg, 
50mg/kg, 300mg/kg and 2000mg/kg of PAVALA PARPAM. The drug was 
administered by oral route single time and observed for 14 days. Daily the animals 
were observed for clinical signs and mortality. Body weight of animals was recorded 
once in a week. 
 There were no physical and general behavioral changes observed in Wistar 
Albino Rats of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rats during 14 days. 
 Body weight of all animals did not reveal any significant change as compared 
to vehicle control group. 
 Food consumption of all group animals was normal. 
 Mortality was not observed in all treatment groups. 
Conclusion: 
 The study shows that PAVALA PARPAM did not produce any toxic effect 
and mortality at dose of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rats. So NO-
Observed-Adverse-Effect-Level(NOAEL) of PAVALA PARPAM is 2000mg/kg. 
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SUB-ACUTE TOXICITY STUDY 
TABLE 21. EFFECT OF PAVALA PARPAM ON BODY WEIGHT DURING 28 DAYS 
TREATMENT IN RATS 
 
Groups Drug Treatment 
Body Weight (gms) 
1st Day 7th Day 14th Day 21st Day 28th Day 
I 
Control - Ghee  
(1ml/kg, p.o) 
168.73± 
3.42 
176.22± 
4.97 
196.34± 
4.77 
210.54± 
6.04 
220.22± 
4.40 
II Pavala Parpam (5mg/kg, p.o) 
162.72± 
5.50 
175.89± 
4.03 
189.32± 
6.43 
208.22± 
3.72 
217.22± 
5.97 
III Pavala Parpam (10mg/kg, p.o) 
159.55± 
6.80 
169.33± 
3.05 
182.55± 
4.25 
200.53± 
5.07 
216.22± 
5.44 
IV Pavala Parpam (20mg/kg, p.o) 
163.77± 
4.80 
175.52± 
5.45 
185.42± 
4.66 
205.68± 
5.30 
218.62± 
5.51 
Values are in mean ± SEM (n=6) 
*P<0.05, **P<0.01, ***P<0.001 Vs Control 
Figure 1. Effect of  Pavala Parpam on body weight during 28 days treatment in rats 
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TABLE 22. EFFECT OF PAVALA PARPAM ON FOOD INTAKE DURING 28 DAYS 
TREATMENT IN RATS 
Groups Drug Treatment 
Food Intake (gms) 
1st Day 7th Day 14th Day 21st Day 28th Day 
I 
Control - Ghee  
(1ml/kg, p.o) 
38.42±1.32 42.56±2.86 39.30±2.20 53.75±3.19 56.90±2.72 
II Pavala Parpam (5mg/kg, p.o) 45.66±2.15 58.73±1.97 54.00±3.98 47.74±3.28 58.25±4.45 
III Pavala Parpam (10mg/kg, p.o) 45.50±2.78 52.26±3.46 68.64±4.81 63.22±3.80 63.75±4.53 
IV Pavala Parpam (20mg/kg, p.o) 45.28±3.22 53.86±3.25 64.70±3.75 62.23±3.84 70.28±2.22 
Values are in mean ± SEM (n=6) 
*P<0.05, **P<0.01, ***P<0.001 Vs Control 
Figure 2. Effect of Pavala Parpam on food intake during 28 days treatment in rats 
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TABLE 23. EFFECT OF PAVALA PARPAM ON WATER INTAKE DURING 28 
DAYS TREATMENT IN RATS 
Groups Drug Treatment 
Water Intake (ml) 
1st Day 7th Day 14th Day 21st Day 28th Day 
I 
Control - Ghee  
(1ml/kg, p.o) 
51.66±2.02 58.76±4.22 64.00±3.90 70.34±4.73 65.76±4.80 
II Pavala Parpam (5mg/kg, p.o) 50.84±3.46 78.31±4.87 60.24±4.00 72.28±5.42 66.26±5.96 
III Pavala Parpam (10mg/kg, p.o) 60.90±3.55 70.00±3.90 70.48±5.46 68.87±5.87 76.23±5.32 
IV Pavala Parpam (20mg/kg, p.o) 75.26±4.76 73.23±5.84 70.54±4.62 80.76±5.62 82.64±4.66 
Values are in mean ± SEM (n=6) 
*P<0.05, **P<0.01, ***P<0.001 Vs Control 
 
Figure 3. Effect of Pavala Parpam on water intake during 28 days treatment in rats 
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TABLE 24. SHOWS THE EFFECT OF PAVALA PARPAM ON RBC, WBC AND HB 
IN RATS AFTER 28 DAYS TREATMENT 
Groups Drug Treatment RBC million 
cells/cmm 
WBC 
cells/cmm 
Haemoglobin 
gm  % 
I 
Control - Ghee  
(1ml/kg, p.o) 
4.57 ±0.16 8638.52±87.66 11.77±0.28 
II Pavala Parpam (5mg/kg, p.o) 4.42 ±0.16 8627.37±107.88 12.14±0.25 
III Pavala Parpam (10mg/kg, p.o) 4.40 ±0.14 8536.87±154.34 11.18±0.37 
IV Pavala Parpam (20mg/kg, p.o) 4.33 ±0.10 8694.20±16.19 11.31±0.43 
Values are in mean ± SEM (n=6) 
*P<0.05, **P<0.01, ***P<0.001 Vs Control 
Figure 4. Shows the effect of Pavala Parpam on RBC and Hb in rats after 28 days 
treatment 
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Figure 5. Shows the effect of Pavala parpam on WBC in rats after 28 days treatment 
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TABLE. SHOWS THE EFFECT OF PAVALA PARPAM ON DIFFERENTIAL 
COUNT IN RATS AFTER 28 DAYS TREATMENT 
 
Groups 
Drug Treatment 
Differential Count % 
Neutophils Eosinophils Monocyte Lympocyte 
I 
Control - Ghee  
(1ml/kg, p.o) 
30.00±1.79 1.17±0.31 3.33±0.42 65.83±1.64 
II Pavala Parpam (5mg/kg, p.o) 29.50±0.22 1.00±0.05 2.83±0.70 66.17±1.35 
III Pavala Parpam (10mg/kg, p.o) 28.00±0.63 1.20±0.06 3.20±0.49 67.20±1.46 
IV Pavala Parpam (20mg/kg, p.o) 26.40±0.51 1.40±0.09 3.00±0.71 69.00±0.71 
Values are in mean ± SEM (n=6) 
*P<0.05, **P<0.01, ***P<0.001 Vs Control 
 
Figure 6. Shows the effect of Pavala Parpam on Differential Counts in rats after 28 days 
treatment 
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TABLE. 25 SHOWS THE EFFECT OF PAVALA PARPAM ON HEPATIC 
FUNCTIONS (SGPT, SGOT AND ALP) IN RATS AFTER 28 DAYS TREATMENT. 
 
Groups 
 
Drug Treatment 
SGPT 
(IU/L) 
SGOT 
(IU/L) 
ALP 
(IU/L) 
I 
Control - Ghee  
(1ml/kg, p.o) 
83.83±1.42 150.17±4.59 270.83±4.17 
II Pavala Parpam (5mg/kg, p.o) 82.00±2.02 153.00±2.02 279.50±3.82 
III Pavala Parpam (10mg/kg, p.o) 88.40±2.66 166.60±3.53 287.40±2.77 
IV Pavala Parpam (20mg/kg, p.o) 108.20±2.08* 185.00±2.12* 302.20±2.27* 
Values are in mean ± SEM (n=6) 
*P<0.05, **P<0.01, ***P<0.001 Vs Control 
Figure 7. Shows the effect of Pavala Parpam on Hepatic Functions  in rats after 28 days 
treatment 
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TABLE. SHOWS THE EFFECT OF PAVALA PARPAM ON KIDNEY FUNCTIONS 
IN RATS AFTER 28 DAYS TREATMENT 
Groups Drug Treatment 
Urea 
(mg/dl) 
Creatinine 
(mg/dl) 
I 
Control - Ghee  
(1ml/kg, p.o) 
34.67±1.12 0.84±0.07 
II Pavala Parpam (5mg/kg, p.o) 35.17±1.58 0.85±0.09 
III Pavala Parpam (10mg/kg, p.o) 47.00±2.65 1.15±0.16 
IV Pavala Parpam (20mg/kg, p.o) 64.60±1.36** 2.12±0.04** 
  Values are in mean ± SEM (n=6) 
  *P<0.05, **P<0.01, ***P<0.001 Vs Control 
Figure 8. Shows the effect of Pavala Parpam on Kidney Functions (Blood Urea and 
Creatinine)  in rats after 28 days treatment 
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TABLE . SHOWS THE EFFECT OF PAVALA PARPAM ON CARDIAC 
FUNCTIONS IN RATS AFTER 28 DAYS TREATMENT 
Groups Drug Treatment 
Creatinine 
Phosphokinase 
(IU/L) 
Lactate 
Dehydrogenase 
(IU/L) 
I 
Control - Ghee  
(1ml/kg, p.o) 
146.83±4.79 543.50±7.72 
II Pavala Parpam (5mg/kg, p.o) 145.83±6.03 599.50±7.36 
III Pavala Parpam (10mg/kg, p.o) 188.60±7.37* 610.40±11.29 
IV Pavala Parpam (20mg/kg, p.o) 229.40±6.96** 678.60±20.99* 
  Values are in mean ± SEM (n=6) 
  *P<0.05, **P<0.01, ***P<0.001 Vs Control 
Figure 9. Shows the effect of Pavala Parpam on Cardiac Functions (Creatinie 
Phosphokinase and Lactate Dehydrogenase and in rats after 28 days treatment 
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Name   : 
Ref. No. : [H0 373A/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY            
 
SPECIMEN                   : BRAIN.  
    
Group – I -A           : PP (High Dose)                   
 
 
    
 
GROSS APPEARANCE: 
 
Received a specimen of brain measuring 3.2x2.5x1.8cms.        
                                
 (PE):  One bit – One block. 
 
 
 
 
MICROSCOPIC APPEARANCE:  
 
            Section from brain with cerebral cortex, 
Cerebellum and Hippo campus shows no significant 
pathology. There is no evidence of toxicity.  
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
Checked 
  
10x shows cortex_brain 
10x shows cerebellum 
10x shows hippocampus 
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Name   : 
Ref. No. : [H0 373B/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                   : Heart. 
    
Group – I-A            : PP (High Dose).    
 
 
 
 
GROSS APPEARANCE: 
 
 Received a specimen of heart measuring 1.4 x1.0x0.5cms 
 (PE): One bit – One block. 
 
 
MICROSCOPIC APPEARANCE:  
 
                     Section studied from the heart shows 
myocardium with myocytes showing no significant 
pathology. The blood vessel shows normal.  
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
Checked 
 
 
  
10x shows myocardium with 
myocytes_heart 
10x shows with blood vessels shows 
normal 
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Name   : 
Ref. No. : [H0 373C/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                   :  Lungs.  
    
Group – I-A            : PP (High Dose) 
 
 
 
GROSS APPEARANCE: 
 
Received a specimen of lung measuring 2.5x2.2x1.6cms. 
 
 (PE): Two bits – One block. 
 
 
MICROSCOPIC APPEARANCE:  
 
Section from lung shows normal alveoli, bronchioles.  
Blood vessels show congestion.   
Septal wall shows chronic inflammatory infiltrates. 
 
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
Checked 
  
10x shows alveoli with bronchioles_ 
lungs 
10x shows chronic inflammatory 
infiltrates 
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Name   : 
Ref. No. : [H0 373D/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
         Toxicity study                
 
SPECIMEN                   :  Liver. 
    
Group – I-A             : PP (High Dose) 
 
 
 
 
GROSS APPEARANCE:  
 
Received a specimen of liver measuring 3.8x2.4x1.5cms. 
 
 (PE): Two bits – One block. 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE:  
 
The sections from the liver shows normal lobular 
architecture. Individual hepatocytes show no significant 
pathology. Portal traid shows mild periportal inflammation 
and bile duct hyperplasia. Sinusoids show mild dilatation. 
Central vein shows congestion. 
 
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
Checked 
  
10x shows lobular architecture 
10x shows individual hepatocytes 
10x shows central vein congestion 
with periportal inflammation 
10x shows sinusoidal dilation 
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Name   : 
Ref. No. : [H0 373E/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                          : Spleen. 
 
Group – I-A                  : PP (High Dose) 
 
 
 
GROSS APPEARANCE    : 
 
Received a Specimen of spleen measuring 3.3cms in length. 
AE: Two bits – One block.  
                                                           
 
MICROSCOPIC APPEARANCE:  
 
 Section studied from the spleen shows normal red pulp 
and hemosiderin laden macrophages. White pulp shows 
prominent lymphoid aggregates with germinal centre 
formation. The pencillar artery shows normal. No evidence 
of toxic changes. 
                                                                      
 
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
Checked 
  
10x shows normal red and white                
pulp spleen 
10x hsows normal red pulp with 
hemosiderin laden macrophages 
_spleen 
10x shows normal white pulp with 
pencillar artery _ testis 
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Name   : 
Ref. No. : [H0 373F/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
         Toxicity study                
 
SPECIMEN                   :  Kidneys 
    
Group – I-A             : PP (High Dose) 
 
 
 
 
 
 
GROSS APPEARANCE:  
 
Received a specimen of kidneys each measuring 
1.2x0.7x0.6cms and 1.2x0.6x0.5cms. 
 
(PE): Two bits – One block. 
 
 
 
 
MICROSCOPIC APPEARANCE:  
 
Section studied from the kidney shows both cortex and 
medulla. The Glomeruli show normal morphology. The 
tubules show no significant pathology. Interstitium shows 
unremarkable. Blood vessels show congestion. 
    
                                                                                      
                                                                                
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
Checked 
 
 
 
10x shows normal glomeruli and  
tubules kidney 
10x shows normaltubules with blood 
vessels congestion 
10x shows interstitium with blod 
vessels congestion 
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Name   : 
Ref. No. : [H0 373G/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                   : Testis.  
    
Group – I-A             : PP (High Dose) 
 
GROSS APPEARANCE: 
 
Received a specimen of testis each measuring 
2.3x1.0x0.6cms and 2.1x1.0x0.5cms.                     
  
(PE):  Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     Section from testis with seminiferous tubules 
showing normal spermatogenesis with varying stages of 
maturation. Leydig cells are normal in number and 
distribution. There is no evidence of toxic changes. 
 
                                                                                      
                                                                                
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
  
10x shows step wise maturation  
testis 
10x shows normal tubules  testis 
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Name   : 
Ref. No. : [H0 374A/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY            
 
SPECIMEN                   : BRAIN.  
    
Group – II-A           : PP (Mid Dose) 
 
GROSS APPEARANCE: 
 
Received a specimen of brain measuring 3.5x2.5x1.6cms.                                         
  
(PE):  One bit – One block. 
 
MICROSCOPIC APPEARANCE:  
 
Section from brain shows normal cerebral cortex, 
cerebellum and hippo campus showing normal 
morphology. There is no evidence of toxicity.  
        
                                                                                    
     
  
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
  
10x shows cortex_brain 
10x shows cerebellum 
10x shows hippocampus 
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Name   : 
Ref. No. : [H0 374B/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                   : Heart. 
    
Group – II-A           : PP (Mid Dose) 
 
GROSS APPEARANCE: 
 
 Received a specimen of heart measuring 1.5 x0.8x0.6cms 
 
 (PE): One bit – One block. 
 
MICROSCOPIC APPEARANCE:  
 
Section studied from the heart shows myocardium with 
myocytes showing no significant pathology. The blood 
vessel shows congestion.  
 
 
                                                                                      
                                                                                 
 
 Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
 
 
10x shows myocardium with 
myocytes_heart 
10x shows with blood vessels shows 
normal 
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Name   : 
Ref. No. : [H0 374C/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                   :  Lungs.  
    
Group – II-A           : PP (Mid Dose) 
 
GROSS APPEARANCE: 
 
 Received a specimen of lung measuring 3.0x2.2x1.4cms. 
 (PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
Section from lung shows normal alveoli, bronchioles. 
Blood vessels show congestion. There is presence of 
interstitial inflammation. 
 
 
 
                                                                      
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
 
 
10x shows alveoli with bronchioles 
lungs 
10x shows scattered inflammatory 
infiltrates and septal wall congestion 
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Name   : 
Ref. No. : [H0 374D/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
         Toxicity study                
 
SPECIMEN                   :  Liver. 
    
Group – II-A           : PP (Mid Dose) 
 
GROSS APPEARANCE:  
 
 Received a specimen of liver measuring 4.2x2.8x1.6cms. 
 
 (PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
The sections from the liver shows mild altered lobular 
architecture. Individual hepatocytes show cytoplasmic 
vacuolation. Portal traid shows mild periportal 
inflammation and bile duct hyperplasia. Sinusoids show 
mild dilatation. Central vein shows no significant 
pathology. 
                                                                          
                                                                                 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
  
10x shows mild altered lobular 
architecture 
10x shows individual hepatocytes 
10x shows central vein congestion 
with periportal inflammation 
10x shows sinusoidal dilation 
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Name   : 
Ref. No. : [H0 374E/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
                      Toxicity study 
 
SPECIMEN                          : Spleen. 
 
Group – II-A                : PP (Mid Dose) 
 
GROSS APPEARANCE    : 
 
Received a Specimen of spleen measuring 3.6cms in 
length. 
AE: Two bits – One block.                                                            
 
MICROSCOPIC APPEARANCE:  
 
 Section studied from the spleen shows normal red pulp 
and hemosiderin laden macrophages. White pulp shows 
prominent lymphoid aggregates with germinal centre 
formation. The pencillar artery shows normal. No 
evidence of toxic changes. 
 
                                                                                     
                                                                                 
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
10x shows normal red and white                
pulp spleen 
10x hsows normal red pulp with 
hemosiderin laden macrophages 
_spleen 
10x shows normal white pulp with 
pencillar artery _ testis 
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Name   : 
Ref. No. : [H0 374F/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
         Toxicity study                
 
SPECIMEN                   :  Kidneys 
    
Group – II-A           : PP (Mid Dose) 
 
GROSS APPEARANCE:  
 
 Received a specimen of kidneys each measuring 
1.4x0.8x0.5cms and 1.3x0.7x0.5cms. 
 
 (PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
Section studied from the kidney shows both cortex and 
medulla. The Glomeruli show normal morphology. The 
tubules show no significant pathology. Interstitium shows 
unremarkable. Blood vessels show unremarkable. 
    
                                                         
                                                                                 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
  
10x shows normal glomeruli and  
tubules kidney 
10x shows normaltubules with blood 
vessels congestion 
10x shows interstitium with blood 
vessels unremarkable 
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Name   : 
Ref. No. : [H0 374G/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
   Toxicity study        
SPECIMEN                   : Ovary.  
    
Group – II-A           : PP (Mid Dose) 
 
GROSS APPEARANCE: 
 
Received a specimen of ovaries each measuring 0.4cms 
and 0.3cms.                     
  
(PE):  Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
Section from ovary shows varying stages of ovarian 
follicle showing normal development with oocyte in the 
center. Stroma shows focal mild inflammatory infiltrates. 
Blood vessels show congestion.  
 
                                                                                      
                                                                                 
 
 
 Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
 
  
10x shows normal ovarian follicles  
ovary 
10x shows scattered inflammatory 
infiltrates and septal wall congestion 
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Name   : 
Ref. No. : [H0 375A/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY            
 
SPECIMEN                     : BRAIN.  
    
Group – III-A           : PP (Low Dose) 
 
GROSS APPEARANCE: 
 
                     Received a specimen of brain measuring 
3.8x2.6x1.5cms.                                         
  
(PE):  One bit – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     Section from brain with cerebral cortex, 
cerebellum hippo campus shows no significant pathology. 
There is no evidence of toxicity.  
        
                                                                                        
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
 
 
 
10x shows cortex_brain 
10x shows cerebellum 
10x shows hippocampus 
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Name   : 
Ref. No. : [H0 375B/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                     : Heart. 
    
Group – III-A           : PP (Low Dose) 
 
GROSS APPEARANCE: 
 
 Received a specimen of heart measuring 1.5 x1.0x0.5cms 
 
 (PE): One bit – One block. 
 
MICROSCOPIC APPEARANCE:  
 
Section studied from the heart myocardium shows mild 
myocyte degeneration extravasated rbc’s. The blood 
vessel shows normal.  
                                                                           
                                                                                 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
 
 
 
 
40x shows mild degenration with 
extravasated rbcs 
10x shows with blood vessels shows 
normal 
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Name   : 
Ref. No. : [H0 375C/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
Toxicity study                
 
SPECIMEN                     :  Lungs.  
    
Group – III-A           : PP (Low Dose) 
 
 
GROSS APPEARANCE: 
 
 Received a specimen of lung measuring 3.0x2.0x1.4cms. 
 
 (PE): Two bits – One block. 
 
 
MICROSCOPIC APPEARANCE:  
 Section from lung shows normal alveoli. Bronchioles 
show mild peribronchiole inflammation. There is 
presence of septal wall congestion and scattered 
lymphocytic infiltrates. 
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
 
10x shows alveoli with bronchioles 
lungs 
10x hows peri bronchial region 
shows inflammatory infiltrates 
10x shows scattered inflammatory 
infiltrates and septal wall congestion 
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Name   : 
Ref. No. : [H0 375D/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
         Toxicity study                
 
SPECIMEN                    :  Liver. 
    
Group – III-A           : PP (Low Dose) 
 
GROSS APPEARANCE:  
 
                     Received a specimen of liver measuring 
4.0x2.5x1.3cms. 
 
 (PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     The sections from the liver shows lobular 
architecture. Individual hepatocytes show cytoplasmic 
vacuolation. Portal traid shows mild periportal 
inflammation. Sinusoids show mild dilatation. Central 
vein shows no significant pathology. 
 
                                                                                       
                                                                                 
 
 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
  
10x shows mild altered lobular 
architecture 
shows cytoplasmic vacuolation 
10x shows central vein congestion 
with periportal inflammation 
10x shows sinusoidal dilation 
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Name   : 
Ref. No. : [H0 375E/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                         : Spleen. 
 
Group – III-A              : PP (Low Dose) 
 
GROSS APPEARANCE    : 
 
Received a Specimen of spleen measuring 3.7cms in 
length. 
AE: Two bits – One block.                                                            
 
MICROSCOPIC APPEARANCE:  
 
 Section studied from the spleen shows normal red pulp 
and hemosiderin laden macrophages. White pulp shows 
prominent lymphoid aggregates with germinal centre 
formation. The pencillar artery shows normal. No 
evidence of toxic changes. 
                                                                              
                                                                                 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
Checked 
 
 
 
 
 
 
  
10x shows normal red and white                
pulp spleen 
10x shows normal red pulp with 
hemosiderin laden macrophages 
_spleen 
10x shows normal white pulp with 
pencillar artery _ testis 
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Name   : 
Ref. No. : [H0 375F/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
HISTOPATHOLOGY 
Toxicity study 
 
SPECIMEN                    :  Kidneys 
    
Group – III-A           : PP (Low Dose) 
 
GROSS APPEARANCE:  
 
                     Received a specimen of kidneys each 
measuring 1.4x0.8x0.6cms and 1.3x0.6x0.6cms. 
 
 (PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     Section studied from the kidney shows both 
cortex and medulla. The Glomeruli show normal 
morphology. The tubules show no significant pathology. 
Interstitium shows unremarkable. Blood vessels show 
congestion. 
    
                                                                                      
                                                                       
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
 
 
 
 
 
 
 
 
 
10x shows normal glomeruli and  
tubules kidney 
10x shows normaltubules with blood 
vessels congestion 
40x shows normal glomeruli and 
tubules with blood vessels 
congestion 
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Name   : 
Ref. No. : [H0 375G/19] 
 
 
Rec.On : 13/04/2019 
Rep.On : 29/04/2019 
 
 
HISTOPATHOLOGY 
   Toxicity study        
 
SPECIMEN                   : Ovary.  
    
Group – III-A         : PP (Low Dose) 
 
GROSS APPEARANCE: 
 
Received a specimen of ovaries each measuring 0.4cms 
and 0.3cms.                     
  
(PE):  Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
Section from ovary shows varying stages of ovarian 
follicle showing normal development with oocyte in the 
center. Stroma shows focal mild inflammatory infiltrates. 
Blood vessels show congestion.  
                                                                                  
                                                                                 
Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
 
Checked 
  
10x shows normal ovarian follicles  
ovary 
10x shows scattered inflammatory 
infiltrates and septal wall congestion 
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6.0 RESULTS: 
 CLINICAL SIGNS: 
All animals in this study were free of toxic signs throughout the dosing period 
of 28 days.  
 
Mortality: 
All animals in control and in all the treated dose groups survived throughout 
the dosing period of 28 days. 
 
 Body weight: 
The effect of PAVALA PARPAM on body weight during 28 days treatment in 
rats was given in table 21. There was no significant change in the body weight 
compared to control with both the doses of PAVALA PARPAM during 28 days 
treatment. 
 
Food consumption: 
  The effect of PAVALA PARPAM on food intake during 28 days treatment in 
rats was given in table 22. PAVALA PARPAM did not alter the food intake at both 
the dose levels as compared to control during the 28 days treatment. It indicates that it 
does not influence food intake. 
 
Water consumption: 
The effect of PAVALA PARPAM on water intake during 28 days treatment in 
rats was given in table 23. PAVALA PARPAM did not alter the water intake at both 
the dose levels as compared to control during the 28 days treatment. There was no 
significant change in water intake as compared to control. 
 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in                  
Table No.24 Comparison of organ weights of treated animals with respective control 
animals on day 28 was found to be comparable similarly. 
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Hematological investigations: 
The results of hematological investigation (Table.25) conducted on 28th day  
revealed following significant changes in the values of different parameters 
investigated when compared with those of respective controls; however, the increase 
or decrease in the values obtained was within normal biological and laboratory limits 
or the effect was not dose dependent. 
 
Biochemical Investigations: 
Results of Biochemical investigations conducted on 28th  day and recorded in 
revealed the following significant changes in the values of hepatic serum enzymes 
studied. When compared with those of respective control. However, the increase or 
decrease in the values obtained was within normal biological and laboratory limits. 
 
Histopathology: 
In histopathological examination, revealed normal architecture in comparison 
with control and treated animal. 
 
DISCUSSION 
The results of acute toxicity study of PAVALA PARPAM were shown on table 3. 
There was no mortality with the Pavala Parpam after 1hr & 24 hrs even at higher dose of 
2000mg/kg. The Pavala Parpam did not alter the general behavior after 1hour of oral 
administration with mild increase in motor activity. After 24hrs of PAVALA PARPAM  oral 
administration, it showed significant increase in motor activity without altering other general 
behavior. It did not show any lethality or toxic reactions during and after the study. From the 
dose mention for human in literatures, 5, 10 and 20mg/kg were selected for further sub-acute 
toxicity study.  
In sub-acute toxicity study, body weight, food intake and water intake were observed 
on 1st, 7th, 14th 21st and 28th day of Pavala Parpam administration. The effect of Pavala Parpam 
on body weight during 28 days treatment in rats was given in table 4 and figure 1. There was 
no significant change in the body weight compared to control with all the three doses of 
Pavala Parpam during 28 days treatment. 
The effect of Pavala Parpam on food intake during 28 days treatment in rats was 
given in table 5 and figure 2. Pavala Parpam did not alter the food intake at both the dose 
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levels as compared to control during the 28 days treatment. It indicates that it does not 
influence food intake.  
The effect of Pavala Parpam on water intake during 28 days treatment in rats was 
given in table 6 and figure 3. Pavala Parpam did not alter the water intake at both the dose 
levels as compared to control during the 28 days treatment. There was no significant change 
in water intake as compared to control. 
Table 7, figure 4 and 5, shows the effect of Pavala Parpam on haematological 
parameters like RBC, WBC and Hb in rats after 28 days treatment. Both the doses of Pavala 
Parpam did not produce any significant change in RBC, WBC and Hb compared to control. 
The effect of Pavala Parpam on Differential Count in rats after 28 days treatment was 
shown on table 8 and figure 6. All the three doses of Pavala Parpam did not show any 
significant change in differential counts like Neutrophils, Eosinpophils, Monocyte and 
Lympocytes. From the effect of Pavala Parpam on hematological parameters it was found that 
it does not produce any toxicity in haemopoietic system. 
The effect of Pavala Parpam on hepatic functions in rats after 28 days treatment was 
shown on table 9 and figure 7. The hepatic enzymes (SGPT, SGOT and ALP) were remaining 
normal with 5 and 10mg/kg of Pavala Parpam. But with the higher dose of Pavala Parpam i.e. 
20mg/kg significantly (P<0.05) increase the levels of SGPT, SGOT and ALP.    
 The effect of Pavala Parpam on renal functions in rats after 28 days treatment was 
shown on table 10 and figure 8. Low and intermediate dose i.e. 5 and 10mg/kg of Pavala 
Parpam does not showed any significant change in urea and creatinine after 28 days treatment 
compared to control. But the higher dose 20mg/kg of Pavala Parpam significantly (P<0.01) 
increased the urea and creatinine compare to control.   
The effect of Pavala Parpam on Cardiac functions in rats after 28 days treatment was 
shown on table 11 and figure 9. Low dose of Pavala Parpam (5mg/kg) did not alter the 
cardiac biomarker enzymes as compared to control animals. Pavala parpam at 10 mg/kg 
significnaly (P<0.01) increase the level of Creatinine Phosphokinase and did not alter the 
levels of Lactate Dehydrogenase compare to control. But the higher dose 20mg/kg of Pavala 
parpam significantly increase the levels of both Creatinie Phosphokinase (P<0.01) and 
Lactate Dehydrogenase (P<0.05) after 28 days administration, compared to control.  
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 CONCLUSION 
    Pavala Parpam was studied for its acute and sub-acue toxicity studies using 
laboratory animals. In acute toxicity study, Pavala Parpam did not produce any specific 
toxicity or mortality even at the dose of 2000mg/kg in mice, but it slightly enhance the motor 
activity. In sub-acute toxicity study, 5, 10 and 20mg/kg of Pavala Parpam was used and it was 
administered once daily for 28 days through oral route. Pavala Parpam did not alter the body 
weight, food intake and water intake during the study period. After 28 days the blood was 
subjected to Hematological, liver, kidney and cardiac function test. All the three doses (5, 10 
and 20mg/kg) of Paval parpam did not showed and change in hematological parameter. The 
higher dose of Pavala parpam (20mg/kg) showed mild toxic effect in Liver, kidney and 
cardiac functions by elevating its specific biomarkers like SGPT, SGOT, ALP, Urea, 
Creatinine, CK phosphokinase and Lactate Dehydrogenase. Form the study it was concluded 
that, Low and moderate dose of Pavala parpam was found to be safe in laboratory animals. 
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BIOSTATISTICAL ASPECTS 
 Biological assay refers to assessment of the potency of vitamins, hormones, 
toxicants and drugs of  all types by means of the responses produced when  doses are 
given to experimental animals. In every dose response situation, two components 
must be considered; the Stimulus and the Subject. 
 The stimulus is applied to the Subject as a stated dose namely concentration, 
weight, time or appropriate measure. The subject manifest a response, the level of 
intensity below which the response does not occur & above which the response occur, 
such a value has often been called threshold. But the term tolerance is now widely 
accepted.  
 
MEDIAN EFFECTIVE DOSE (ED50) 
 It is the dose which produces the desired response in half the animal 
population tested. 
 
MEDIAN LETHAL DOSE (LD 50) 
 It is the dose which kills half the population of the animal tested.  
 
LD50 Measurment( Toxicity) 
• If the test compound shows any pharmacological activity then the 
LD50 of the drug is determined. 
• By determining the LD50, we can justify whether to proceed with the 
drug or not. 
Table  - 26 
Acute Toxicity Study Analysis 
Group Dose in mg / kg No. of rats No. of  rats died 
I 
Distilled water 
(1ml/kg) 
3 - 
II 5 3 - 
III 50 3 - 
IV 300 3 - 
V 2000 3 - 
 
 Since there was no mortality of the animal in acute toxicity study, lethal dose 
of drug could not be calculated.  
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Table  - 27 
Subacute Toxicity Study Analysis 
Group Dose (mgs / kg) No. of rats 
 
Days 
 
No. of rats 
died 
I Control 6 (3 M + 3F) 28 - 
II 5mg 6 (3 M + 3F) 28 - 
III 10mg 6 (3 M + 3F) 28 - 
IV 20mg 6 (3 M + 3F) 28 - 
  
  In case of Subacute Toxicity Study, with the help of physiological parameters 
such as Hematological investigations and with the histopathological studies the drug 
reaction within the animal can be assessed and are being tabulated respectively. 
 Lethal dose of the drug “PAVALA PARPAM ” can be calculated with higher 
dose level of the drug which can be done in further studies. 
  From the above biostatistical measures “PAVALA PARPAM”  is safe upto the 
dose level 20mg/kg body weight of the animal. 
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8.  DISCUSSION 
 
 The present study with PAVALA PARPAM  was conducted with an objective to 
find out whether this drug has got any side effects or adverse reactions in short 
and Long term administration 
 ICP OES analysis indicates that Aluminium, Arsenic, Cadmium, Copper, 
Mercury,  Nickel and  Lead are  in below detection Limit. 
 FTIR analysis of PAVALA PARPAM  indicates the presence of Aromatic 
compounds, Alkynes, Alkene, Alkyl halide, Alcohol, Acyl chloride, Esters, 
Carboxylic acids, Amides and Amines. 
 SEM analysis indicated that the particle size were in Range  2 - 1 micron. 
 Biochemical Analysis of PAVALA PARPAM  indicates the presence of Calcium, 
Sulphate, Chloride, Carbonate and Ferrous iron. 
 On the basis of acute toxicity study results the study shows that PAVALA 
PARPAM  did not produce any toxic up ot the dose of 2000mg/kg to rats. 
 On the basis of subacute toxicity Results, the study reveals that PAVALA 
PARPAM  did not cause either any lethality or adverse changes with general 
behaviour in rats and also there were no observable detrimental effects                       
(5 -20 mg/kg body weight) over a period of 28 day. 
 In histopathological examination revealed normal architecture in comparison with 
control and treated animal. 
 Haematological analysis revealed no abnormalities attributable to the treatment. 
 These results indicate that PAVALA PARPAM  upto 5 - 20mg/kg body weight did 
not produce any toxicity effects in long term administration. 
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9. SUMMARY 
 
 The medicine PAVALA PARPAM  was taken for the dissertation work based on  
Kannu Sammy, Parambarai Vaithiyam, Page No :385, 386 
 The aim of this dissertation is to study the acute and sub-acute toxicity of the 
medicine PAVALA PARPAM administered at various presumed moderate 
dosage, in the experimental animals. 
 The Ingredients of PAVALA PARPAM  are Pavalam and Thaivelai.  The pavalam 
were purchased from fishermen of Tiruchendur Seashore and Thaivelai collected 
from Moolikulam region. 
 The raw samples were taken for purification and the test medicine was prepared, 
as per the method narrated in the literature. 
 The drug was analysed for its physicochemical properties and contents by using 
qualitative biochemical analysis and modern techniques such as inductively 
couped plasma-optical emission spectrometry. 
 Depending upon the result of these analysis the contents of test sample was 
identified. 
 By scanning electron microscope (SEM), the size of the particles about                    
2-1 micron, were analyzed. 
 The study was done at Department of  Pharmacology, Nandha College of 
Pharmacy, Erode District. 
 To evaluate the acute toxicity study 15 rats were selected and divided into                        
5 groups (Group I,II,III,IV,V) and they were administered with the drug with 
different graded doses ranging from Control, 5mg/kg, 50mg/kg, 300mg/kg and 
2000mg/kg body weight of animal orally with control group.  Daily the animals 
were observed for clinical signs and mortality.  The drug did not produce any 
mortality and is safe upto 2000mg/kg body weight. 
 Sub acute Toxicity was conducted for about 28 days duration.  No signs of 
toxicity was observed in animals from different dose groups during the dosing 
period. 
 The haematological index shows no significant changes 
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 During long term administration of the drugs at both low dose and high dose 
SGOT, SGPT, Serum Urea, Serum Creatinine level found to be within the normal 
range. 
 Biostatistical measures to the acute and subacute toxicity studies shows the drugs 
“PAVALA PARPAM ” found to be safe up to  2000mg/kg body weight of the 
animal in acute toxicity study and found to be safe upto 20mg/kg body weight of 
the animal in sub-acute toxicity study. 
  In this study since there is no mortality, the lethal dose of drug could not be 
calculated  
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10. CONCLUSION 
 
From acute toxicity study it was observed that the administration of PAVALA 
PARPAM  up to the  dose of 2000 mg/kg to the Wistar Albino Rats did not produce 
drug-related toxicity and mortality. So No-Observed-Adverse-Effect- Level (NOAEL) 
of PAVALA PARPAM  is 2000 mg/kg. 
 
The subacute toxicity studies also reveals that the drug “PAVALA PARPAM” 
can be considered safe, as it did not produce either any lethality or adverse changes 
with general behaviour of rats and also there were not observable determental effects 
in the doses (5 to 20mg/kg body weight)  over a period of 28 days.  It is concluded 
that the “PAVALA PARPAM ” is relatively  safe in long administration upto the dose 
of 20mg/kg. 
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